AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Investor AB

Annual Report Jan 20, 2023

2931_rns_2023-01-20_d1d128e4-c277-4599-93c6-d24ba461b6db.pdf

Annual Report

Open in Viewer

Opens in native device viewer

Year-End Report

January-December 2022

"Much of what defined 2022 will undoubtedly also define 2023. While uncertainty is high, Investor and our companies are well prepared to handle the challenges and capture the opportunities that lie ahead. Regardless of market environment, our companies benefit from being industry leaders with good profitability and exposure to secular growth areas."

Johan Forssell, President & CEO of Investor

Highlights during the fourth quarter

  • Adjusted net asset value (NAV) amounted to SEK 673,250m (SEK 220 per share) on December 31, 2022, an increase of SEK 46,958m, or 7 percent, including dividend added back, during the quarter. Total shareholder return amounted to 16 percent, compared to 11 percent for the SIXRX return index. For 2022, adjusted net asset value growth amounted to -10 percent and total shareholder return to -15 percent, compared to -23 percent for SIXRX.
  • Listed Companies generated a total return of 12 percent.
  • Based on estimated market values, the total return for Patricia Industries, excluding cash, amounted to -4 percent (-4 percent including cash), negatively impacted by multiple contraction and currency effects.
  • Within Patricia Industries, sales growth for the major subsidiaries amounted to 32 percent, of which 11 percent organically in constant currency. Adjusted EBITA grew by 34 percent.
  • Mölnlycke reported organic sales growth of 9 percent in constant currency. The EBITA margin declined by 3 percentage points, negatively impacted by a reorganization of the structure of Customer Care and production disturbances in the US Wound Care manufacturing plant. Mölnlycke distributed EUR 300m to Patricia Industries.
  • The value change of Investments in EQT was 2 percent. Net cash flow to Investor amounted to SEK 1,426m.
  • Leverage was 1.5 percent as of December 31, 2022 (1.9 percent as of December 31, 2021). Gross cash amounted to SEK 28,533m and the average maturity of Investor AB's debt portfolio was 11.8 years on December 31, 2022.
  • The Board of Directors proposes a dividend per share of SEK 4.40 (4.00) to be paid in two installments, SEK 3.30 in May, 2023 and SEK 1.10 in November, 2023.

Financial information*

12/31 2022 9/30 2022 12/31 2021
Adjusted NAV, SEK m* 673,250 626,292 760,962
Adjusted NAV, SEK per share* 220 204 248
Reported NAV, SEK m*1) 604,865 554,683 682,614
Reported NAV, SEK per share*1) 197 181 223
Market capitalization (both share classes), excluding repurchased shares, SEK m 584,163 510,961 711,230
Share price (B-share), SEK 188.56 163.58 227.75
Q4 2022 2022
Adjusted NAV, sequential change, incl. dividend added back, SEK m* 46,958 -75,458
Adjusted NAV, sequential change, incl. dividend added back, %* 7 -10
Reported NAV, sequential change, incl. dividend added back, SEK m*1) 50,182 -65,495
Reported NAV, sequential change, incl. dividend added back, %*1) 9 -10
Market capitalization, sequential change, incl. dividend added back, SEK m* 76,265 -114,813
Market capitalization, sequential change, incl. dividend added back, %* 12 -16
Q4 2022 Q4 2021 2022 2021
Consolidated net sales, SEK m 14,168 11,037 51,812 40,737
Consolidated profit/loss, SEK m 51,567 81,091 -74,762 227,965
Basic earnings per share, SEK 16.82 26.47 -24.38 74.45
* Financial measures that are not defined or specified in the applicable financial reporting framework. For more information, see page 18 and 30-31. Change in market capitalization

with dividend added back reflects the change in total market capitalization with the dividend paid out added back. Change in net asset value with dividend added back includes the full dividend approved by the AGM.

1) In the reported net asset value, the wholly-owned subsidiaries and partner-owned investments within Patricia Industries are reported according to the acquisition and equity method respectively. Methods are further described in Investor AB's Annual Report.

Overview annual average performance

1 year 5 years 10 years 20 years
Adjusted NAV incl. dividend added back, % -9.9 14.0
Investor B, total return, % -15.4 17.8 19.3 17.9
SIXRX return index, % -22.8 9.8 12.1 12.3

CEO statement

Dear fellow shareholders,

During the fourth quarter, our adjusted net asset value grew by 7 percent and our total shareholder return amounted to 16 percent, compared to 11 percent for the SIXRX return index.

2022 was certainly challenging for the global economy, defined by sharply rising inflation and interest rates, soaring energy prices,

continued disruptions in global supply chains, and the lingering pandemic, but most of all by the terrible Russian invasion of Ukraine. Against this background, Investor and our portfolio showed strong resilience, with adjusted net asset value outperforming the Swedish stock market. Adjusted net asset value growth and total shareholder return amounted to -10 and -15 percent respectively, compared to -23 percent for the SIXRX. In an increasingly complex and fast-changing environment, Investor and our portfolio companies took important initiatives to futureproof our businesses:

  • Overall, our companies within Listed Companies and Patricia Industries performed well, investing in strategic initiatives, while adapting to the volatile macro environment. Important steps were taken to further reduce the climate footprint in operations, and to develop and launch energyefficient, environmentally-friendly products.
  • EQT combined with Baring Private Equity Asia, expanding significantly in Asia. Net cash flow to Investor reached a record level.
  • Despite investments, our financial position strengthened further, driven by good cash flow.

Listed Companies

Listed Companies' total return was -5 percent during 2022, compared to -23 percent for the SIXRX. The outperformance was driven by strong absolute returns in Saab and our healthcare holdings, as well as significant outperformance by large holdings such as ABB, SEB and Nasdaq.

During the year, our companies proceeded with strategic initiatives. For example, ABB divested the remaining part of the power grids business and spun off Accelleron to its shareholders. Husqvarna continued its shift from petroldriven to electrified products. Atlas Copco made several acquisitions to further strengthen its position in key areas, and AstraZeneca made successful progress within its oncology franchise. Ericsson continued to strengthen its compliance culture and, in early 2023, announced actions to improve profitability within Cloud Software and Services.

At the end of the year, Epiroc announced the acquisition of the Australian company CR Mining, expanding its offering of innovative consumables and digital solutions.

Patricia Industries

During the fourth quarter, based on estimated market values, Patricia Industries' total return was -4 percent, driven by lower multiples and negative currency impact, mitigated by higher earnings. The full year total return was -2 percent.

For the full year, sales growth for the major subsidiaries amounted to 28 percent, of which 9 percent organic in constant currency. Adjusted EBITA grew by 20 percent.

During the fourth quarter, organic sales grew 11 percent in constant currency, while adjusted EBITA grew 34 percent.

A key highlight was Permobil, reporting strong organic growth and a doubling of the operating profit. BraunAbility, Laborie and Sarnova all reported good underlying growth and margin expansion. Advanced Instruments had a tougher quarter, while Piab's reported margin was affected by costs relating to strategic projects.

During the quarter, Mölnlycke grew 9 percent organically in constant currency, mainly driven by Wound Care and Gloves, while profitability declined. The low margin in the quarter was negatively impacted by a reorganization of the Customer Care structure, and disturbances in the US Wound Care manufacturing plant due to staff shortages and supply issues, causing extra costs. Furthermore, capacity utilization in the new Gloves factory in Malaysia was low during ramp-up. The utilization rate is expected to gradually improve and management is making all efforts to normalize the US manufacturing situation.

Investments in EQT

In the quarter, the reported value of Investments in EQT increased by 2 percent and net cash flow to Investor amounted to SEK 1.4bn. During 2022, the value decreased by 35 percent, driven by EQT AB, while net cash flow to Investor amounted to a record SEK 6.2bn.

Financial position, dividend proposal

Our financial position strengthened further during the quarter, mainly driven by a EUR 300m distribution from Mölnlycke, the strong cash flow from EQT and proceeds from the divestiture of passive infrastructure in Three Scandinavia. At year-end, leverage amounted to 1.5 percent. With substantial gross cash, no debt maturities until 2029, and an underlying strong cash flow generation, our financial flexibility is high. Against this background, Investor's board of directors proposes a SEK 4.40 per share dividend for fiscal year 2022, an increase of 10 percent compared to last year.

Going forward

The world is getting increasingly complex. Technology is advancing at great speed, the climate challenge needs to be handled urgently, and the geopolitical situation has deteriorated significantly. In addition, there are a number of political initiatives such as the Green Deal and the Inflation Reduction Act, that have substantial impact on many companies. As an engaged owner, we support our companies in trying to understand the implications of these over-arching complexities and how to position themselves in order to future-proof their businesses.

Much of what defined 2022 will undoubtedly also define 2023. While uncertainty is high, Investor and our companies are well prepared to handle the challenges and capture the opportunities that lie ahead. Regardless of market environment, our companies benefit from being industry leaders with good profitability and exposure to secular growth areas.

Our business model of building high-quality, industryleading companies through engaged ownership is well proven. Combined with our financial strength and all the dedicated people at Investor and in our companies, I am confident in our ability to continue to generate long-term attractive total returns to you, dear fellow shareholders.

Johan Forssell President & CEO

INVESTOR Q4 2022 – 3

Net asset value overview

Adjusted values Reported values
Number of Ownership Share of total Value, Value, Value, Value,
shares
12/31 2022
capital/votes (%)
12/31 2022
assets (%)
12/31 2022
SEK m
12/31 2022
SEK m
12/31 2021
SEK m
12/31 2022
SEK m
12/31 2021
Listed Companies
Atlas Copco 836,131,135 17.0/22.3 15 102,091 128,968 102,091 128,968
ABB 265,385,142 13.5/13.5 12 83,944 91,732 83,944 91,732
AstraZeneca 51,587,810 3.3/3.3 11 72,403 54,807 72,403 54,807
SEB 456,198,927 20.9/21.0 8 54,646 57,458 54,646 57,458
Epiroc 207,757,845 17.1/22.7 6 39,075 47,298 39,075 47,298
Nasdaq 58,182,426 11.8/11.8 5 37,249 36,835 37,249 36,835
Sobi 107,594,165 34.7/34.7 3 23,270 19,957 23,270 19,957
Saab 40,972,622 30.2/39.7 2 16,852 9,440 16,852 9,440
Ericsson 266,745,735 8.0/23.8 2 16,849 26,589 16,849 26,589
Wärtsilä 104,711,363 17.7/17.7 1 9,196 13,242 9,196 13,242
Electrolux 50,786,412 17.9/30.4 1 7,151 11,089 7,151 11,089
Husqvarna 97,052,157 16.8/33.4 1 7,122 13,986 7,122 13,986
Accelleron1) 13,269,257 14.0/14.0 0 2,868 - 2,868 -
Electrolux Professional 58,941,654 20.5/32.4 0 2,579 3,677 2,579 3,677
Total Listed Companies 70 475,296 515,078 475,296 515,078
Patricia Industries Total exposure (%)
Subsidiaries
Mölnlycke2) 99 9 58,888 72,926 18,780 17,787
Laborie 98 2 15,991 14,727 9,580 8,276
Sarnova 96 2 12,674 11,099 8,029 6,527
Permobil2) 98 2 11,651 10,747 5,211 4,363
Advanced Instruments 98 1 10,073 6,952 8,575 7,082
Piab2) 96 1 7,869 8,029 6,189 5,702
BraunAbility 93 1 5,222 3,641 2,388 2,365
Vectura 99 1 3,845 3,630 3,821 3,705
Atlas Antibodies 93 0 2,807 2,960 2,853 2,313
Total subsidiaries 19 129,019 134,710 65,424 58,120
Three Scandinavia 40/40 1 7,504 6,801 2,7143) 5,043
Financial Investments 0 1,972 2,594 1,972 2,594
Total Patricia Industries excl. cash 20 138,495 144,106 70,110 65,758
Total Patricia Industries incl. cash 150,317 156,611 81,933 78,263
Investments in EQT
EQT AB 174,288,016 14.6/14.7 6 38,500 85,872 38,500 85,872
Fund investments 5 31,550 30,768 31,550 30,768
Total Investments in EQT 10 70,050 116,640 70,050 116,640
Other Assets and Liabilities 0 -328 -371 -328 -371
Total Assets excl. cash Patricia Industries 100 683,513 775,453 615,128 697,105
Gross debt* -38,796 -38,446 -38,796 -38,446
Gross cash* 28,533 23,955 28,533 23,955
Of which Patricia Industries 11,823 12,505 11,823 12,505
Net debt -10,263 -14,491 -10,263 -14,491
Net Asset Value 673,250 760,962 604,865 682,614
Net Asset Value per share 220 248 197 223

1) On September 7, 2022 an Extraordinary General Meeting in ABB decided to spin-off Accelleron from ABB and distribute the Accelleron shares to the shareholders of ABB as a dividend in kind. The first day of trading in Accelleron was October 3, 2022. SEK 2,683m has been transferred from the value of ABB to the value of Accelleron on the date of the distribution.

2) Including receivables related to Management Participation Program foundations. For Mölnlycke, the receivable corresponds to less than 1 percentage point of the total exposure, for Permobil to approximately 2 percentage points and for Piab to approximately 4 percentage points.

3) Negatively impacted by a write-down on network assets following a change in useful life.

Overview

For balance sheet items, figures in parentheses refer to year-end 2021 figures. For income statement and cash flow items, they refer to the same period last year.

Net asset value

During 2022, adjusted net asset value decreased from SEK 761.0bn to SEK 673.2bn. The change in adjusted net asset value, with dividend added back, was -10 percent during the period (41), of which 7 percent during the fourth quarter (12).

Reported net asset value decreased from SEK 682.6bn to SEK 604.9bn. The change in reported net asset value, with dividend added back, was -10 percent during the period (50), of which 9 percent during the fourth quarter (14).

Total adjusted assets by business area

Net debt and cash flow

Net debt totaled SEK 10,263m on December 31, 2022 (14,491), corresponding to leverage of 1.5 percent (1.9).

Our target leverage range is 0-10 percent (net debt/total adjusted assets) over a business cycle. While leverage can fluctuate above and below the target level, it should not exceed 20 percent for a longer period of time.

Gross cash amounted to SEK 28,533m and gross debt to SEK 38,796m as of December 31, 2022. The average maturity of Investor AB's debt portfolio was 11.8 years on December 31, 2022 (10.8).

Investor's net debt

SEK m 2022
Opening net debt -14,491
Listed Companies
Dividends 10,935
Other capital distributions 1,662
Investments, net of proceeds -517
Management cost -148
Total 11,932
Patricia Industries
Proceeds 4,807
Investments -2,205
Internal transfer to Investor -3,124
Management cost -336
Other1) 174
Total -683
Investments in EQT
Proceeds (divestitures, fee surplus and carry) 10,220
Drawdowns (investments and management fees) -3,989
Management cost -11
Total 6,220
Investor groupwide
Dividend to shareholders -12,254
Internal transfer from Patricia Industries 3,124
Management cost -130
Other2) -3,981
Closing net debt -10,263
1) Incl. currency related effects and net interest paid.

2) Incl. currency related effects, revaluation of debt and net interest paid.

Management cost

Investor's management cost amounted to SEK 188m during the fourth quarter 2022 (158).

As of December 31, 2022, rolling 12-month management cost amounted to 0.09 percent of the adjusted net asset value.

The Investor share

The price of the Investor A-share and B-share was SEK 193.85 and SEK 188.56 respectively on December 31, 2022, compared to SEK 238.60 and SEK 227.75 on December 31, 2021.

The total shareholder return (Class B-share) amounted to -15 percent during 2022 (55), of which 16 percent during the fourth quarter (21).

The SIXRX return index was -23 percent during 2022 (39), of which 11 percent during the fourth quarter (12).

Investor's market capitalization, excluding repurchased shares, was SEK 584,163m as of December 31, 2022 (711,230).

Listed Companies

Listed Companies include ABB, Accelleron, AstraZeneca, Atlas Copco, Electrolux, Electrolux Professional, Epiroc, Ericsson, Husqvarna, Nasdaq, Saab, SEB, Sobi and Wärtsilä. These are multinational companies with strong market positions and proven track records. In general, they are well positioned and we work continuously to support them to remain or become best-in-class.

Highlights during the quarter

• Listed Companies generated a total return of 12 percent, mainly driven by strong performance in our largest holdings.

Performance

Total return (excluding management costs) amounted to -5 percent during 2022, of which 12 percent during the fourth quarter.

The SIXRX return index was -23 percent during 2022, of which 11 percent during the fourth quarter.

Contribution to net asset value (adjusted and reported) amounted to SEK -27,851m during 2022 (159,327), of which SEK 52,267m during the fourth quarter (53,320).

Contribution to net asset value

SEK m Q4 2022 2022 2021
Changes in value 50,895 -38,638 148,616
Dividends 1,416 10,935 10,834
Management cost -45 -148 -123
Total 52,267 -27,851 159,327

Contribution to net asset value and total return

Q4 2022 2022
Value,
SEK m
Contribution,
SEK m
Total
return
(%)1)
Contribution,
SEK m
Total
return
(%)
Atlas Copco 102,091 15,741 18.2 -24,132 -18.6
ABB 83,944 6,192 11.4 -5,583 -3.1
AstraZeneca 72,403 8,667 13.6 19,015 35.2
SEB 54,646 5,725 11.7 -88 0.7
Epiroc 39,075 6,329 19.3 -7,600 -16.0
Nasdaq 37,249 684 1.8 852 2.4
Sobi 23,270 86 0.4 3,313 16.6
Saab 16,852 2,647 18.6 7,613 81.1
Ericsson 16,849 -783 -4.4 -9,073 -34.5
Wärtsilä 9,196 1,706 22.8 -3,773 -28.4
Electrolux 7,151 1,255 21.3 -3,471 -30.9
Husqvarna 7,122 1,280 21.9 -6,576 -46.9
Accelleron 2,868 2,868 6.9 2,868 6.9
Electrolux
Professional
2,579 -86 -3.2 -1,069 -29.2
Total 475,296 52,311 12.4 -27,703 -5.2

1) Calculated as the sum of share price changes with reinvested dividends, including add-on investments and/or divestments.

Dividends received

Dividends received totaled SEK 10,935m during 2022 (10,834), of which SEK 1,416m during the fourth quarter (3,134). In addition, 13,269,257 shares in Accelleron Industries AG were received as a dividend in kind during the fourth quarter 2022.

Redemption programs

Redemptions received totaled SEK 1,662m during 2022, of which SEK 1,662m during the second quarter, relating to the mandatory redemption program in Atlas Copco.

Dividends received, Listed Companies

Investments and divestments

During 2022, investments amounted to SEK 501m, of which SEK 0m during the fourth quarter. The investments relate to the purchase of 5,114,571 B-shares in Atlas Copco during the third quarter.

Divestments amounted to SEK 1,662m, of which SEK 1,662m during the second quarter, relating to the divestment of 207,754,141 redemption rights in Atlas Copco's mandatory redemption program.

Listed Companies, value distribution, December 31, 2022

Patricia Industries

Patricia Industries develops wholly-owned companies in the Nordics and in North America. Holdings include Advanced Instruments, Atlas Antibodies, BraunAbility, Laborie, Mölnlycke, Permobil, Piab, Sarnova, Vectura, Three Scandinavia and Financial Investments.

Highlights during the quarter

  • The major subsidiaries reported strong sales and profit growth.
  • Mölnlycke distributed EUR 300m to Patricia Industries.

Operating performance

During 2022, sales growth for the major subsidiaries was 28 percent. Organic growth was 9 percent in constant currency. EBITA amounted to SEK 9,217m, an increase of 21 percent. Adjusting for items affecting comparability, mainly related to transaction and integration costs, EBITA grew by 20 percent.

During the fourth quarter 2022, sales growth amounted to 32 percent. Organic growth was 11 percent in constant currency. EBITA amounted to SEK 2,442m, an increase of 39 percent. Adjusted EBITA grew by 34 percent.

During 2022, the companies' (subsidiaries and 40 percent of Three Scandinavia) combined sales amounted to SEK 54.3bn, while EBITDA amounted to SEK 12.3bn. The corresponding figures for the fourth quarter were SEK 14.9bn and SEK 3.3bn respectively.

Patricia Industries, adjusted values, December 31, 2022

Reported EBITDA (subsidiaries & 40% of Three Scandinavia)

Major subsidiaries, performance

Q4 2022

Org. growth,
constant
Operating
SEK m Sales currency EBITDA EBITDA (%) EBITA1) EBITA, (%) cash flow
Mölnlycke 5,179 9 1,158 22.2 974 18.7 849
Laborie 949 9 308 32.7 288 30.6 148
Sarnova 2,621 6 437 16.8 389 15.0 307
Permobil 1,545 17 389 25.1 335 21.7 252
Advanced Instruments 376 -5 121 32.1 115 30.6 72
Piab 661 7 122 18.4 97 14.7 113
BraunAbility 2,589 25 254 9.9 198 7.7 149
Vectura 78 9 42 53.9 10 12.5 -160
Atlas Antibodies 98 9 42 42.8 36 37.0 17
Total 14,098 2,872 20.4 2,442 17.3 1,747
Reported growth y/y, % 32 34 39
Organic growth, y/y, % 11

2022

Org. growth,
constant
Operating
SEK m Sales currency EBITDA EBITDA (%) EBITA1) EBITA, (%) cash flow
Mölnlycke 19,432 4 5,064 26.1 4,362 22.4 3,171
Laborie 3,434 12 983 28.6 915 26.7 495
Sarnova 9,283 2 1,370 14.8 1,198 12.9 1,034
Permobil 5,248 9 1,071 20.4 880 16.8 435
Advanced Instruments 1,359 7 457 33.6 436 32.1 359
Piab 2,450 11 619 25.2 530 21.6 411
BraunAbility 9,402 28 874 9.3 680 7.2 465
Vectura 302 28 178 58.9 50 16.7 -614
Atlas Antibodies 398 14 187 47.0 165 41.4 94
Total 51,309 10,802 21.1 9,217 18.0 5,850
Reported growth y/y, % 28 20 21
Organic growth, y/y, % 9

1) EBITA is defined as operating profit before acquisition-related amortizations.

Value development

Contribution to adjusted net asset value amounted to SEK -3,321m during 2022 (3,694), of which SEK -5,857m during the fourth quarter (-2,063).

Contribution to adjusted net asset value

SEK m Q4 2022 2022 2021
Changes in value -5,777 -3,009 3,933
Management cost -96 -336 -261
Other 16 23 21
Total -5,857 -3,321 3,694

Based on estimated market values, the total return for Patricia Industries, excluding cash, amounted to -2 percent (-2 percent including cash) during 2022, of which -4 percent during the fourth quarter (-4 percent including cash). The negative return during the fourth quarter was driven by lower multiples and negative currency effects, partly offset by higher earnings.

For more information on valuation, see page 35.

Investments and divestments

During 2022, investments amounted to SEK 2,204m, of which SEK 9m during the fourth quarter. Investments mainly relate to equity investments in Advanced Instruments, Piab, Laborie and Permobil earlier during the year.

Divestments amounted to SEK 373m, of which SEK 69m during the fourth quarter. Within Financial Investments, 24Health divested the Doktor24 business during the fourth quarter.

Distributions received

During 2022, distributions to Patricia Industries amounted to SEK 4,434m, of which SEK 4,343m during the fourth quarter. Out of these, SEK 3,247m relates to Mölnlycke. Regarding the distribution from Three Scandinavia related to the divestment of its passive network infrastructure, approximately SEK 3.2bn has previously been received and approximately SEK 1.1bn in cash and SEK 0.6bn worth of Cellnex shares was received during the fourth quarter. In total, SEK 4.9bn has been received from the divestment.

Distribution to Patricia Industries

Patricia Industries, net cash
SEK m Q4 2022 2022 2021
Beginning of period 7,495 12,505 13,468
Net cash flow 4,404 2,602 2,125
Internal transfer to Investor - -3,124 -2,938
Other1) -76 -161 -150
End of period 11,823 11,823 12,505
1) Includes currency-related effects, net interest and management cost.
Patricia Industries – valuation overview
Estimated market
values, SEK m,
12/31, 2022
Change Q4
2022 vs. Q3
2022 SEK m
Major drivers Comments
Subsidiaries
Mölnlycke 58,888 -8,523 Lower multiples impacted negatively,
SEK 3.2bn distribution to Patricia
Industries
Applied EV/reported LTM EBITDA 14.6x
Laborie 15,991 -1,288 Lower multiples and currency impacted
negatively, mitigated by higher earnings
Applied EV/adj. LTM EBITDA 17.5x
Sarnova 12,674 234 Higher earnings impacted positively,
currency impacted negatively
Implied EV/reported LTM EBITDA 13.3x.
Acquisition of Allied 100 valued at cost
Permobil 11,651 2,570 Higher earnings impacted positively,
lower multiples impacted negatively
Applied EV/adj. LTM EBITDA 14.2x
Advanced Instruments 10,073 -1,559 Lower multiples and currency impacted
negatively
Applied EV/adj. LTM EBITDA 17.9x.
Acquisitions of Solentim and Artel valued at
cost
Piab 7,869 237 No major drivers Applied EV/adj. LTM EBITDA 15.5x
BraunAbility 5,222 443 Higher earnings impacted positively,
lower multiples and currency impacted
negatively. Acquisition of Q'Straint at
estimated market value for the first time
Implied EV/reported LTM EBITDA 9.5x
Vectura 3,845 13 No major drivers Estimated market value of the property
portfolio less debt and cost
Atlas Antibodies 2,807 -146 No major drivers Implied EV/reported LTM EBITDA 17.9x
Partner-owned
investments
Three Scandinavia 7,504 -1,574 Lower multiples impacted negatively,
SEK 1.1bn distribution of proceeds from
divestment of passive network
infrastructure
Applied EV/LTM adj. EBITDA 6.7x. The
estimated market value includes a discounted
value of the Cellnex shares received
Financial Investments 1,972 -590 Multiple or third-party valuation, share price
Total 138,495
Total incl. cash 150,317

A provider of single-use products and solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Read more at www.molnlycke.com

Activities during the quarter

Group

  • Reported sales grew by 13 percent, of which 9 percent organically in constant currency, mainly driven by Wound Care and Gloves.
  • The EBITA margin was negatively impacted during the quarter by a reorganization of the structure of Customer Care, and production disturbances in the US Wound Care manufacturing plant, the latter due to staff shortages and supply issues causing extra costs. In addition, the new Gloves factory in Malaysia is ramping up, with capacity utilization expected to improve gradually during 2023. Currency also impacted negatively.
  • Mölnlycke distributed EUR 300m to Patricia Industries.
  • Mölnlycke submitted a letter of commitment to the Science Based Target initiative (SBTi) to align greenhouse gas emissions targets with the ambitions of the Paris Climate Agreement.

Wound Care

  • Organic sales growth amounted to 9 percent in constant currency driven by strong underlying demand in all regions, together with successful commercial execution.
  • Mölnlycke's new offering within negative pressure wound therapy is now being commercialized within both the US and EMEA.
  • Mölnlycke continued to invest significantly to further strengthen market positions and support sustainable growth.

Operating Room Solutions

  • Organic sales growth amounted to 4 percent in constant currency driven by Trays and Drapes.
  • Elective surgery activity has gradually improved over the past year. However, global nurse shortages restrain this improvement.

Gloves

• Organic sales growth amounted to 23 percent in constant currency, with strong underlying demand in both the US and EMEA, while the comparison period from 2021 was negatively impacted by covid-related production shutdowns.

Antiseptics

• Organic sales growth amounted to 5 percent in constant currency, with an improved product supply situation in the US.

Mölnlycke, sales and margin development

Key figures, Mölnlycke

Income statement items, 2022 2021
EUR m Q4 YTD Q4 YTD
Sales 474 1,828 420 1,686
EBITDA 105 476 106 485
EBITA 89 410 89 421
Sales growth, % 13 8 -24 -6
Organic growth,
constant currency, %
9 4 -26 -6
EBITDA, % 22.2 26.1 25.1 28.8
EBITA, % 18.7 22.4 21.2 25.0
Cash flow items, EUR m Q4 YTD Q4 YTD
EBITDA 105 476 106 485
Lease payments -7 -22 -5 -21
Change in working capital 0 -86 44 -34
Capital expenditures -21 -70 -17 -49
Operating cash flow 78 298 128 382
Acquisitions/divestments - -1 - -
Shareholder contribution/distribution -300 -300 -50 -250
Other1) 20 -108 -19 -150
Increase(-)/decrease(+) in net debt -202 -111 58 -18
Key ratios
Working capital/sales, % 18
Capital expenditures/sales, % 4
Balance sheet items, EUR m 12/31 2022 12/31 2021
Net debt 1,621 1,510
12/31 2022 12/31 2021
Number of employees 8,775 8,315

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

Mölnlycke, distribution of sales and organic sales growth

Share of sales, (%)
Last 12 months
Organic growth,
constant currency, (%)
Q4 2022
Wound Care 58 9
Operating Room
Solutions
25 4
Gloves 14 23
Antiseptics 3 5
Total 100 9

Mölnlycke, distribution of sales by geography

Share of sales, (%)
2022
Europe, Middle East, Africa 56
Americas 35
Asia Pacific 9
Total 100

A provider of diagnostic and therapeutic products within Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. Read more at www.laborie.com

Activities during the quarter

  • Organic sales growth amounted to 9 percent in constant currency. Underlying market demand was strong, but global supply chain challenges continued to negatively impact performance. Growth was mainly driven by UR (Urology), with the OptilumeTM urethral strictures product continuing to see strong commercial uptake.
  • Driven by operating leverage, the EBITA margin increased despite negative currency impact, elevated input costs, as well as significant investments in R&D and several new product launches, including OptilumeTM.

Key figures, Laborie

Income statement items, 2022 2021
USD m Q4 YTD Q4 YTD
Sales 89 339 84 313
EBITDA 29 97 22 93
EBITA 27 90 20 83
Sales growth, % 6 8 20 36
Organic growth,
constant currency, %
9 12 14 21
EBITDA, % 32.7 28.6 26.4 29.9
EBITA, % 30.6 26.7 24.2 26.6
Cash flow items, USD m Q4 YTD Q4 YTD
EBITDA 29 97 22 93
Lease payments 0 -2 -1 -4
Change in working capital -13 -39 0 -20
Capital expenditures -2 -7 -1 -10
Operating cash flow 14 49 20 60
Acquisitions/divestments - -167 -74 -74
Shareholder contribution/distribution - 100 - -
Other1) -8 -11 -4 -8
Increase(-)/decrease(+) in net debt 6 -30 -58 -22
Key ratios
Working capital/sales, % 20
Capital expenditures/sales, % 2
Balance sheet items, USD m 12/31 2022 12/31 2021
Net debt 454 424
12/31 2022 12/31 2021
Number of employees 895 780

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A US provider of specialty healthcare and safety products, services and software for the US emergency medical services (EMS), acute care and cardiac response markets. Read more at www.sarnova.com

Activities during the quarter

  • Organic sales grew by 6 percent in constant currency, driven by the Acute and Cardiac Response business units. The Acute business benefitted from a normalized flu season and the Cardiac Response business continued to see strong customer demand and recovery from the prior quarters' supply chain challenges related to the availability of Automated External Defibrillators (AEDs).
  • Adjusted for transaction costs in the prior year, the EBITA margin increased from 12 to 15 percent, driven by good operating performance partially offset by continued investments in digital platform enhancement and warehouse optimization.

Key figures, Sarnova

Income statement items, 2022 2021
USD m Q4 YTD Q4 YTD
Sales 245 917 233 835
EBITDA 41 135 30 104
EBITA 37 118 25 91
Sales growth, % 6 10 17 15
Organic growth,
constant currency, %
6 2 0 0
EBITDA, % 16.8 14.8 13.1 12.5
EBITA, % 15.0 12.9 10.9 10.9
Cash flow items, USD m Q4 YTD Q4 YTD
EBITDA 41 135 30 104
Lease payments -1 -4 -1 -4
Change in working capital -9 -11 3 6
Capital expenditures -2 -18 -11 -29
Operating cash flow 29 102 21 77
Acquisitions/divestments - - - -289
Shareholder contribution/distribution - - - 210
Other1) -14 -60 -12 -41
Increase(-)/decrease(+) in net debt 15 43 9 -44
Key ratios
Working capital/sales, % 14
Capital expenditures/sales, % 2
Balance sheet items, USD m 12/31 2022 12/31 2021
Net debt 526 569
12/31 2022 12/31 2021
Number of employees 1,435 1,370

A provider of advanced mobility and seating rehab solutions, including powered and manual wheelchairs, pressure-relieving cushions and powerassist devices. Read more at www.permobil.com

Activities during the quarter

  • Organic sales growth amounted to 17 percent in constant currency, supported by all regions.
  • Last year's EBITA margin was negatively impacted by a strategic development project. Adjusting for this, the margin still increased significantly, primarily driven by operating leverage and currency.
  • Permobil continued to invest in its sustainable supply chain and optimization of packaging, supporting the journey towards lowered CO2e emissions.

Key figures, Permobil

Income statement items, 2022 2021
SEK m Q4 YTD Q4 YTD
Sales 1,545 5,248 1,119 4,062
EBITDA 389 1,071 192 782
EBITA 335 880 149 612
Sales growth, % 38 29 10 3
Organic growth,
constant currency, %
17 9 6 6
EBITDA, % 25.1 20.4 17.2 19.2
EBITA, % 21.7 16.8 13.3 15.1
Cash flow items, SEK m Q4 YTD Q4 YTD
EBITDA 389 1,071 192 782
Lease payments -16 -68 -19 -62
Change in working capital -48 -295 -91 -330
Capital expenditures -73 -273 -45 -175
Operating cash flow 252 435 37 214
Acquisitions/divestments - -280 - -262
Shareholder contribution/distribution - 350 - -
Other1) 170 -668 -178 -559
Increase(-)/decrease(+) in net debt 422 -164 -140 -607
Key ratios
Working capital/sales, % 26
Capital expenditures/sales, % 5
Balance sheet items, SEK m 12/31 2022 12/31 2021
Net debt 3,330 3,166
12/31 2022 12/31 2021
Number of employees 1,805 1,660

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A provider of scientific and analytical instruments for the biotechnology, clinical and food & beverage industries. Read more at www.aicompanies.com

Activities during the quarter

  • Organic sales growth declined by 5 percent in constant currency, negatively impacted by weak instrument sales to biopharmaceutical customers and a notably strong prior year comparison. This was partly offset by continued strong growth in services and strong performance for the recently launched OsmoPro MAX automated osmometer for clinical laboratory customers.
  • Adjusted for transaction costs in the current and prior year, the EBITA margin declined by approximately 9 percentage points from 44 to 35 percent. The decrease is mainly explained by weaker instrument sales and continued substantial investments in the global commercial organization, general and administrative functions, and R&D. Furthermore, the margin was negatively affected by product mix impact following the Artel and Solentim acquisitions.

Key figures, Advanced Instruments

Income statement items, 2022 2021
USD m Q4 YTD Q4 YTD
Sales 35 134 31 103
EBITDA 11 45 12 38
EBITA 11 43 11 37
Sales growth, % 13 31 45 34
Organic growth,
constant currency, %
-5 7 18 24
EBITDA, % 32.1 33.6 37.1 37.1
EBITA, % 30.6 32.1 35.8 35.7
Cash flow items, USD m Q4 YTD Q4 YTD
EBITDA 11 45 12 38
Lease payments 0 -1 0 -1
Change in working capital -4 -7 -1 -3
Capital expenditures 0 -1 -1 -2
Operating cash flow 7 35 10 32
Acquisitions/divestments - -77 - -238
Shareholder contribution/distribution - 50 - 170
Other1) -7 -20 -2 -7
Increase(-)/decrease(+) in net debt 0 -11 8 -43
Key ratios
Working capital/sales, % 12
Capital expenditures/sales, % 1
Balance sheet items, USD m 12/31 2022 12/31 2021
Net debt 206 195
12/31 2022 12/31 2021
Number of employees 370 225

A provider of gripping and moving solutions for end-users and machine manufacturers to improve energy efficiency, productivity and work environment. Read more at www.piab.com

Activities during the quarter

  • Organic sales growth amounted to 7 percent in constant currency, driven by all regions. Lifting Automation showed the strongest growth.
  • The EBITA margin declined, negatively impacted by costs related to strategic projects, as well as currency effects.
  • Within Vacuum Automation, Piab launched Kenos® Safe&Light, a lightweight gripping tool for palletizing applications in packaging and warehousing.

Key figures, Piab

Income statement items, 2022 2021
SEK m Q4 YTD Q4 YTD
Sales 661 2,450 472 1,738
EBITDA 122 619 109 485
EBITA 97 530 81 409
Sales growth, % 40 41 8 14
Organic growth, 7 11 8 18
constant currency, %
EBITDA, % 18.4 25.2 23.1 27.9
EBITA, % 14.7 21.6 17.2 23.5
Cash flow items, SEK m Q4 YTD Q4 YTD
EBITDA 122 619 109 485
Lease payments -11 -41 -8 -32
Change in working capital 26 -95 -9 -42
Capital expenditures -24 -72 -13 -35
Operating cash flow 113 411 79 376
Acquisitions/divestments - -715 -254 -254
Shareholder contribution/distribution - 210 - -60
Other1) 48 -569 -87 -256
Increase(-)/decrease(+) in net debt 161 -663 -262 -193
Key ratios
Working capital/sales, % 18
Capital expenditures/sales, % 3
Balance sheet items, SEK m 12/31 2022 12/31 2021
Net debt 2,431 1,767
12/31 2022 12/31 2021
Number of employees 1,030 695

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A provider of mobility transportation solutions, including wheelchair accessible vehicles, lifts and seating, storage and securement products. Read more at www.braunability.com

Activities during the quarter

  • Organic sales growth amounted to 25 percent in constant currency, driven by strong pent-up demand in the commercial WAVs (Wheelchair Accessible Vehicle) and lifts segments as supply chain constraints eased. The Q'Straint securement products also showed good growth.
  • The EBITA margin improved, driven by operating leverage, partly offset by a negative impact from increased material and labor costs.

Key figures, BraunAbility

Income statement items, 2022 2021
USD m Q4 YTD Q4 YTD
Sales 242 929 184 692
EBITDA 24 86 13 52
EBITA 19 67 9 35
Sales growth, % 32 34 22 22
Organic growth,
constant currency, %
25 28 14 17
EBITDA, % 9.9 9.3 7.2 7.5
EBITA, % 7.7 7.2 4.6 5.1
Cash flow items, USD m Q4 YTD Q4 YTD
EBITDA 24 86 13 52
Lease payments -2 -7 -2 -9
Change in working capital -5 -21 1 7
Capital expenditures -2 -12 -4 -12
Operating cash flow 14 46 8 38
Acquisitions/divestments - -8 - -76
Shareholder contribution/distribution - - - 20
Other1) -10 -22 -1 -94
Increase(-)/decrease(+) in net debt 4 16 7 -111
Key ratios
Working capital/sales, % 7
Capital expenditures/sales, % 1
Balance sheet items, USD m 12/31 2022 12/31 2021
Net debt 284 300
12/31 2022 12/31 2021
Number of employees 1,945 1,825

Develops and manages properties within community service and commercial with a long-term commitment. Read more at www.vectura.se

Activities during the quarter

  • Total sales growth amounted to 9 percent, driven by new Community Services properties.
  • The EBITDA margin declined, as growth was somewhat counteracted by higher costs due to the expansive project portfolio.
  • A 1,700 m2 rental agreement was signed with Atlas Antibodies in Forskaren. Additional rental agreements were signed in Bromma Sjukhus and GoCo House. Both Forskaren and GoCo House have reached 70 percent occupancy.
  • During 2022, the market value of Vectura's property increased, mainly due to investments in ongoing construction projects and recent acquisitions, while underlying property value decreased due to yield expansion.

Key figures, Vectura

Income statement items, 2022 2021
SEK m Q4 YTD Q4 YTD
Sales 78 302 71 279
EBITDA 42 178 42 172
EBITDA, % 53.9 58.9 59.2 61.5
EBITA adj.1) 10 50 7 45
EBITA adj % 12.5 16.7 9.5 16.0
Balance sheet items, SEK m 12/31 2022 12/31 2021
Net debt 5,223 3,963
12/31 2022 12/31 2021
Real estate market value 9,650 8,388
12/31 2022 12/31 2021
Number of employees 49 33

1) EBITA adjusted for depreciation of surplus values related to properties.

A provider of advanced reagents for basic and clinical biomedical research. Read more at www.atlasantibodies.com

Activities during the quarter

  • Organic sales growth amounted to 9 percent in constant currency, driven by the evitria business.
  • The EBITA margin decreased compared to last year, impacted by investments to build the commercial organization.
  • Atlas Antibodies announced that it will relocate its headquarters to Forskaren, a developing life science hub in Hagastaden, Stockholm. The relocation will take place in 2024.
  • Åsa Riisberg was appointed new Chair, effective January 1, 2023.

Key figures, Atlas Antibodies

Income statement items, 2022 2021
SEK m Q4 YTD Q4 YTD
Sales 98 398 81 324
EBITDA 42 187 42 162
EBITA 36 165 37 143
Sales growth, % 21 23 23 31
Organic growth,
constant currency, %
9 14 19 34
EBITDA, % 42.8 47.0 51.4 50.1
EBITA, % 37.0 41.4 45.0 44.2
Cash flow items, SEK m Q4 YTD Q4 YTD
EBITDA 42 187 42 162
Lease payments -2 -8 -2 -6
Change in working capital -21 -68 -12 -32
Capital expenditures -2 -17 -4 -9
Operating cash flow 17 94 24 115
Acquisitions/divestments - - - -2,629
Shareholder contribution/distribution - - - 2,030
Other1) -7 -30 0 -39
Increase(-)/decrease(+) in net debt 10 64 23 -522
Key ratios
Working capital/sales, % 45
Capital expenditures/sales, % 4
Balance sheet items, SEK m 12/31 2022 12/31 2021
Net debt 342 406
12/31 2022 12/31 2021
Number of employees 130 115

Provides mobile voice and broadband services in Sweden and Denmark. Read more at www.tre.se.

Activities during the quarter

  • The subscription base increased by 62,000, of which 53,000 in Sweden and 9,000 in Denmark.
  • Service revenue increased by 10 percent and EBITDA by 5 percent, negatively impacted by higher energy expenses.
  • Three Sweden won the network test by Open Signal, based on customer experience, appointed "Best mobile network in Sweden and fastest on 5G" due to major investments and significantly improved network.
  • Three Denmark launched Flexii, a digital self-service and low cost brand.
  • The final payment related to the divestment of passive network infrastructure was received.
Key figures, Three Scandinavia
2022 2021
Income statement items Q4 YTD Q4 YTD
Sales, SEK m 3,283 11,834 2,925 10,750
Sweden, SEK m 2,160 7,668 1,929 6,946
Denmark, DKK m 756 2,904 730 2,787
Service revenue, SEK m1) 1,947 7,505 1,763 6,913
Sweden, SEK m 1,220 4,752 1,138 4,402
Denmark, DKK m 489 1,920 458 1,839
EBITDA, SEK m 973 3,729 931 3,535
Sweden, SEK m 706 2,732 636 2,564
Denmark, DKK m 180 694 216 711
EBITDA, % 29.7 31.5 31.8 32.9
Sweden 32.7 35.6 33.0 36.9
Denmark 23.8 23.9 29.6 25.5
Key ratios
Capital expenditures/sales, % 22
Balance sheet items, SEK m 12/31 2022 12/31 2021
Net debt 7,294 6,498
12/31 2022 12/31 2021
Number of employees 1,790 1,735
Other key figures 12/31 2022 12/31 2021
Subscriptions 4,004,000 3,834,000
Sweden 2,464,000 2,337,000
Denmark 1,540,000 1,496,000

1) Mobile service revenue excluding interconnect revenue.

Investments in EQT

EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. Investor was one of the founders of EQT in 1994 and has committed capital to the vast majority of its funds. Read more at www.eqtgroup.com

Highlights during the quarter

  • The reported value change of Investments in EQT was 2 percent. Net cash flow to Investor amounted to SEK 1,426m.
  • EQT AB completed its combination with Baring Private Equity Asia.

Performance

Contribution to net asset value (adjusted and reported) amounted to SEK -40,370m during 2022 (63,988), of which SEK 1,216m during the fourth quarter (27,596).

The reported value change of Investor's investments in EQT was -35 percent during 2022, of which -37 percent in constant currency.

During the fourth quarter, the value change amounted to 2 percent, of which 1 percent in constant currency.

Net cash flow to Investor amounted to SEK 6,220m during 2022, of which SEK 1,426m during the fourth quarter.

Investments in EQT AB

Total shareholder return for 2022 amounted to -55 percent, of which 1 percent during the fourth quarter.

Dividends received amounted to SEK 488m during 2022, of which SEK 244m during the fourth quarter.

Investments in EQT funds

Investor reports the value change on its EQT fund investments with a one-quarter lag. Consequently, the information related to Investor's investments in EQT funds in this report is presented as of September 30, 2022.

During 2022, the reported value change of Investor's investments in EQT funds amounted to 21 percent, of which 13 percent in constant currency.

During the fourth quarter, the reported value change amounted to 2 percent, of which 1 percent in constant currency.

Investor's total outstanding commitments to EQT funds amounted to SEK 25.6bn as of December 31, 2022 (11.1).

Change in adjusted net asset value, EQT

SEK m Q4 2022 2022 2021
Net asset value, beginning of
period
70,260 116,640 57,486
Contribution to net asset value
Drawdowns (investments,
1,216 -40,370 63,988
management fees and management
cost)
832 4,000 8,068
Proceeds to Investor (divestitures,
fee surplus, carry and dividend)
-2,257 -10,220 -12,902
Net asset value, end of period 70,050 70,050 116,640

Investor's investments in EQT, December 31, 20221)

Fund
size
EUR m
Share (%) Outstanding
commitment
SEK m
Reported
value
SEK m
Fully invested funds2) 38,019 3,291 14,612
EQT IX 15,600 3 1,079 5,698
EQT Infrastructure IV 9,100 3 637 3,282
EQT Infrastructure V 15,700 3 2,488 3,084
Credit Opportunities III3) 1,272 10 555 682
EQT Growth 2,200 3 546 147
EQT Ventures II 619 3 13 318
EQT Ventures III 1,000 3 287 62
EQT Mid Market Asia III 630 27 215 1,690
EQT Mid Market Europe 1,616 9 260 1,774
EQT Real Estate II 1,000 3 183 163
EQT new funds - - 16,052 38
Total fund investments 86,756 25,607 31,550
EQT AB 14.6/14.74) 38,500
Total investments in EQT 70,050

Investor

1) Following the IPO of EQT AB in September 2019, Investor's investments in EQT funds are reported with a one-quarter lag. 2) EQT V, EQT VI, EQT VII, EQT VIII, EQT Expansion Capital II, EQT Greater China II, EQT Infrastructure I, II, III and IV, EQT Credit Fund II, EQT Mid Market, EQT Mid Market US, EQT Real Estate I, EQT Ventures.

3) Divested by EQT AB to Bridgepoint, October 2020.

4) Capital and votes respectively.

Investor's investments in EQT, key figures overview

SEK m FY
2022
Q4
2022
Q3
2022
Q2
2022
Q1
2022
FY
2021
Q4
2021
Q3
2021
Q2
2021
Q1
2021
FY
2020
Q4
2020
Reported value 70,050 70,050 70,260 69,647 99,078 116,640 116,640 90,889 78,467 75,566 57,486 57,486
Reported value
change, %
-35 2 2 -26 -15 111 30 16 9 30 55 16
Value change,
constant currency, %
-37 1 1 -27 -15 110 30 16 9 29 57 18
Drawdowns from
Investor
4,000 832 428 847 1,893 8,068 3,120 2,258 1,169 1,520 4,630 377
Proceeds to Investor 10,220 2,257 1,355 4,660 1,947 12,902 4,965 2,550 4,986 401 4,801 908
Net cash flow to
Investor
6,220 1,426 927 3,813 54 4,834 1,845 292 3,817 -1,119 171 531

Investor Group

Net debt

Net debt totaled SEK 10,263m on December 31, 2022 (14,491). Debt financing of the Patricia Industries' subsidiaries is arranged without guarantees from Investor and hence not included in Investor's net debt. Investor guarantees SEK 2.4bn of the associated company Three Scandinavia's refinanced external debt, but this guaranteed loan is not included in Investor's net debt either. The same applies for pending dividends from investments and approved but not yet paid dividend to shareholders.

Net debt, December 31, 2022

SEK m Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
net debt
Other financial
investments
Cash, bank and short
9,705 -116 9,590
term investments
Receivables included
26,304 -7,361 18,943
in net debt 945 -148 797
Interest bearing debt -91,220 51,728 -39,492
Provision for pensions -799 699 -101
Total -55,065 44,802 -10,263

Investor's gross cash amounted to SEK 28,533m as of December 31, 2022 (23,955). The short-term investments are invested conservatively, taking into account the riskadjusted return profile. Investor's gross debt, excluding pension liabilities, amounted to SEK 38,695m as of December 31, 2022 (38,337).

The average maturity of Investor AB's debt portfolio was 11.8 years on December 31, 2022 (10.8), excluding the debt of the Patricia Industries subsidiaries.

Investor is rated AA- (Stable Outlook) by S&P Global and Aa3 (Stable Outlook) by Moody's.

In January 2023, a SEK 8bn (10) revolving credit facility was refinanced and its maturity extended by five years, with an option of another two years' additional extension. The facility remains undrawn.

Debt maturity profile, December 31, 2022

Net financial items, 2022

SEK m Group -
Net financial
items
Deductions
related to
Patricia
Industries
Investor's net
financial
items
Interest income 81 -18 62
Interest expenses
Results from revaluation of
loans, swaps and short
-2,489 1,574 -915
term investments -602 58 -543
Foreign exchange result -2,951 461 -2,490
Other -300 246 -53
Total -6,261 2,321 -3,940

Parent Company

Share capital

Investor's share capital amounted to SEK 4,795m on December 31, 2022 (4,795).

Share structure
Class of
share
Number of
shares
Number of
votes
% of
capital
% of
votes
A 1 vote 1,246,763,376 1,246,763,376 40.6 87.2
B 1/10 vote 1,821,936,744 182,193,674 59.4 12.8
Total 3,068,700,120 1,428,957,050 100.0 100.0

Investor's share capital consists of 3,068,700,120 shares with a quota of SEK 1.5625 per share.

On December 31, 2022, Investor owned a total of 5,654,344 of its own shares (5,242,353).

Results and investments

The Parent Company's result after financial items was SEK -28,395m (136,791). The result is mainly related to Listed Companies which contributed to the result with dividends amounting to SEK 10,224m (10,286) and value changes of SEK -34,990m (126,711).

During 2022, the Parent Company invested SEK 3,349m in financial assets (3,621), of which SEK 495m in Group companies (0) and purchases in Listed Companies of SEK 501m (1,520). The Parent Company divested SEK 8,650m in Group Companies (800) and SEK 1,662m (519) in Listed Companies during the year. By the end of the period, Shareholder's equity totaled SEK 431,034m (471,763).

Other

Annual General Meeting

Investor AB's Annual General Meeting will be held on May 3, 2023, at 3:00 p.m. at China Teatern, Berzelii Park 9, Stockholm, Sweden. Notification of participation in the Annual General Meeting can be made from March 24, 2023. Additional information about Investor's Annual General Meeting will be available on Investor's website. Investor's audited Annual Report in Swedish will be made available at the company's head office and website no later than April 12, 2023.

Dividend Proposal

The Board of Directors proposes a dividend to the shareholders of SEK 4.40 per share for fiscal year 2022 (4.00). The dividend is proposed to be paid out in two

installments, SEK 3.30 with record date May 5, 2023 and SEK 1.10 with record date November 6, 2023. Should the Annual General Meeting decide in favor of the proposal, payment of the dividend is expected to be made on May 10, 2023, and on November 9, 2023. The dividend level proposed is based on the stated dividend policy to pay a steadily rising dividend, supported by cash flow from our three business areas: Listed Companies, Patricia Industries and Investments in EQT.

Acquisitions (business combinations)

Piab's acquisition of AVAC Vakuumteknik

On August 9, 2022 Piab finalized the acquisition of AVAC Vakuumteknik AB, a vacuum automation specialist company. The consideration amounted to SEK 23m. In the preliminary purchase price allocation, goodwill amounted to SEK 15m. AVAC complements Piab with a solid portfolio of products and solutions covering a wide range of applications, a highly experienced and skilled team as well as new customers. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 1m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, AVAC contributed net sales of SEK 4m and profit/loss of SEK 1m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 9m and consolidated profit/loss for the period would have increased by SEK 1m.

Advanced Instrument's acquisition of SAL Scientific

On August 1, 2022, Advanced Instruments completed the acquisition of SAL Scientific Ltd, a private company that develops and manufactures a portfolio of cell growth supplements. The consideration amounted to SEK 62m. In the preliminary purchase price allocation, goodwill amounted to SEK 0m. The acquisition will support the expansion of regent technologies and deliver additional inhouse capabilities that support ongoing technology adoption, new product innovation and enhanced customer support. Transaction related costs amounted to SEK 2m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, SAL contributed net sales of SEK 0m and profit/loss of SEK 1m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 0m and consolidated profit/loss for the period would have increased by SEK 1m.

Advanced Instrument's acquisition of Artel

On June 13, 2022, Advanced Instruments completed the acquisition of Artel, a leading provider of calibration and validation instruments, consumables, software and services used by life science laboratories. The consideration amounted to SEK 797m. In the preliminary purchase price allocation, goodwill amounted to SEK 639m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 29m and derive from external legal fees and due diligence expenses. These costs have

been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Artel contributed net sales of SEK 116m and profit/loss of SEK 13m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 97m and consolidated profit/loss for the period would have increased by SEK 11m.

Piab's acquisition of Joulin

On May 19, 2022, Piab completed the acquisition of 95 percent of Joulin, a French provider of vacuum grippers and gantry robots for automated wood handling and other segments. The consideration amounted to SEK 622m. In the preliminary purchase price allocation, goodwill amounted to SEK 530m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 8m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Joulin contributed net sales of SEK 94m and profit/loss of SEK 19m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 62m and consolidated profit/loss for the period would have increased by SEK 21m.

Piab's acquisition of Manut-LM

On February 9, 2022, Piab completed the acquisition of Manut-LM, a French leading tube lifting company. The consideration amounted to SEK 75m. In the preliminary purchase price allocation, goodwill amounted to SEK 56m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 1m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Manut-LM contributed net sales of SEK 53m and profit/loss of SEK 2m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 9m and consolidated profit/loss for the period would have increased by SEK 1m.

Permobil's acquisition of Panthera

On January 3, 2022, Permobil completed the acquisition of Panthera, a leading company in ultra-light active wheelchairs. The consideration amounted to SEK 305m. In the final purchase price allocation, goodwill amounted to SEK 241m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies' product portfolios. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 6m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Panthera contributed net sales of

Identifiable assets acquired and liabilities assumed

SEK m AVAC SAL Artel Joulin Manut-LM Panthera Total
Intangible assets - 78 499 0 1 0 578
Property, plant and equipment 2 - 63 4 3 9 81
Other financial investments - - - 0 0 6 6
Inventories 3 1 43 36 9 48 140
Trade receivables 2 1 35 21 15 19 93
Other current receivables 0 0 5 2 1 1 10
Cash and cash equivalents 3 5 56 87 21 25 197
Long-term interest bearing liabilities - -2 -47 - -6 -16 -72
Deferred tax liabilities - -19 -129 - - -4 -151
Other liabilities -2 -1 -368 -28 -25 -24 -448
Net identifiable assets and liabilities 8 62 158 123 20 64 435
Non-controlling interest - - - -31 - - -31
Consolidated goodwill 15 - 639 530 56 241 1,481
Consideration 23 62 797 622 75 305 1,885

Pledged assets and contingent liabilities

Total pledged assets amount to SEK 29.8bn (24.8), of which SEK 27.5bn (23.4) refers to pledged assets in the subsidiaries BraunAbility, Laborie, Advanced Instruments and Sarnova, related to outstanding loans corresponding to SEK 2.6bn, SEK 4.6bn, SEK 2.1bn and SEK 5.3bn. The increase in pledged assets mainly relates to increased assets in the subsidiaries.

Total contingent liabilities amount to SEK 1.6bn and refers to warranties within the wholly-owned subsidiaries (1.1).

Risks and uncertainties

The main risks that the Group and the Parent Company are exposed to are primarily related to the value changes of the listed assets due to market price fluctuations. The current uncertain market environment creates unpredictable near-term fluctuations in the financial markets. The global market development also affects Investor's unlisted holdings' businesses. The global economy continues to be affected by geopolitical tensions, Russia's invasion of Ukraine, supply chain constraints as well as increased inflation and interest. Investor's portfolio companies operate in several different industries, and they all face different situations. Based on Investor's governance model, each individual board and management team decides on appropriate actions related to the company's risks.

All companies have taken measures related to Russia's invasion of Ukraine to follow sanctions, to protect and support employees, and several have wound down their Russian activities. The direct exposure to Russia and Ukraine is very small for Investor and its subsidiaries and the direct financial impact from the war is negligible. However, the indirect impact due to fluctuations in the financial markets, higher prices on raw materials, inflation and central bank policies, can be substantial, but it is not possible to quantify these effects for the coming year. In 2022, Investor's net sales to Russia and Ukraine amounted to SEK 75m, corresponding to 0.14 percent of net sales for the Group. The Group has no production plants or other assets in the countries concerned. During 2022 no impairment has been made related to Russia's invasion of Ukraine.

Investor's risk management, risks and uncertainties are described more in detail in the Annual Report, (Administration report and Note 3).

Accounting policies

For the Group, this Year-End Report is prepared in accordance with IAS 34 Interim Financial Reporting and applicable regulations in the Swedish Annual Accounts Act, and for the Parent Company in accordance with Sweden's Annual Accounts Act, chapter 9 Interim report. The accounting policies that have been applied for the Group and Parent Company, are in agreement with the accounting policies used in preparation of the company's most recent annual report.

Alternative Performance Measures

Investor applies the ESMA Guidelines on Alternative Performance Measures (APMs). An APM is a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. For Investor's consolidated accounts, this framework typically means IFRS.

Definitions of all APMs used are found in the Annual Report 2021 and on www.investorab.com/investorsmedia/investor-in-figures/definitions.

Reconciliations to the financial statements for the APMs that are not directly identifiable from the financial statements and considered significant to specify, are disclosed on pages 30-31. Reconciliations of APMs for individual subsidiaries or business areas are not disclosed, since the purpose of these are to give deeper financial information without being directly linked to the financial information for the Group, that is presented according to the applicable financial reporting framework.

Roundings

Due to rounding, numbers presented throughout this Year-End Report may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Financial calendar

Apr. 21, 2023 Interim Management Statement
January-March 2023
May 3, 2023 Annual General Meeting
Jul. 17, 2023 Interim Report
January-June 2023
Oct. 19, 2023 Interim Management Statement
January-September 2023

Jan. 19, 2024 Year-End Report 2023

Stockholm, January 20, 2023

Johan Forssell President and Chief Executive Officer

For more information

Helena Saxon Chief Financial Officer +46 8 614 2000 [email protected]

Viveka Hirdman-Ryrberg Head of Corporate Communication and Sustainability +46 70 550 3500 [email protected]

Magnus Dalhammar Head of Investor Relations +46 73 524 2130 [email protected]

Address

Investor AB (publ) (CIN 556013-8298) SE-103 32 Stockholm, Sweden Visiting address: Arsenalsgatan 8C Phone: +46 8 614 2000 www.investorab.com

Ticker codes

INVEB SS in Bloomberg INVEb.ST in Reuters INVE B in NASDAQ OMX

Information about Investor is also available on LinkedIn.

This information is information that Investor AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:15 CET on January 20, 2023.

This Year-End Report and additional information is available on www.investorab.com

Review Report

Introduction

We have reviewed the Interim report of Investor AB (publ), corporate identity number 556013-8298, for the period January 1-December 31, 2022. The Board of Directors and the President are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.

Scope of Review

We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review has a different focus and is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (ISA) and other generally accepted auditing practices. The procedures performed in a review do not enable us to obtain a level of assurance that would

make us aware of all significant matters that might be identified in an audit.

Therefore, the conclusion expressed based on a review does not give the same level of assurance as a conclusion expressed based on an audit.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the Interim report is not, in all material respects, prepared for the Group in accordance with IAS 34 and the Annual Accounts Act, and for the Parent Company in accordance with the Annual Accounts Act.

Stockholm, January 20, 2023

Deloitte AB

For signature, please see Swedish version

Jonas Ståhlberg

Authorized Public Accountant

Consolidated Income Statement, in summary

SEK m 2022 2021 H2 2022 H2 2021 Q4 2022 Q4 2021
Dividends 11,427 11,254 2,974 4,397 1,661 3,346
Changes in value -82,783 213,505 58,602 104,178 51,046 77,903
Net sales 51,812 40,737 27,883 21,393 14,168 11,037
Cost of goods and services sold -28,546 -21,743 -15,434 -11,602 -7,876 -5,997
Sales and marketing cost -7,708 -6,072 -4,093 -3,173 -2,130 -1,631
Administrative, research and development and other
operating cost
-9,824 -8,420 -5,030 -4,833 -2,591 -2,124
Management cost -624 -530 -340 -277 -188 -158
Share of results of associates -1,176 2,938 -1,184 75 -1,200 -20
Operating profit/loss -67,423 231,669 63,378 110,158 52,889 82,356
Net financial items -6,261 -3,347 -2,768 -1,985 -773 -1,141
Profit/loss before tax -73,684 228,322 60,610 108,173 52,116 81,215
Income taxes -1,079 -357 -726 -147 -550 -124
Profit/loss for the period -74,762 227,965 59,884 108,027 51,567 81,091
Attributable to:
Owners of the Parent Company -74,681 228,065 59,901 108,064 51,529 81,098
Non-controlling interest -81 -100 -17 -38 38 -7
Profit/loss for the period -74,762 227,965 59,884 108,027 51,567 81,091
Basic earnings per share, SEK -24.38 74.45 19.56 35.28 16.82 26.47
Diluted earnings per share, SEK -24.38 74.41 19.55 35.26 16.81 26.46

Consolidated Statement of Comprehensive Income, in summary

SEK m 2022 2021 H2 2022 H2 2021 Q4 2022 Q4 2021
Profit/loss for the period -74,762 227,965 59,884 108,027 51,567 81,091
Other comprehensive income for the period, including tax
Revaluation of property, plant and equipment 13 21 13 21 13 21
Re-measurements of defined benefit plans 254 46 188 25 190 26
Items that may be recycled to profit/loss for the period
Cash flow hedges 76 68 26 25 3 14
Hedging costs 121 -12 44 5 -43 -13
Foreign currency translation adjustment 8,954 3,518 2,657 2,162 -1,533 996
Share of other comprehensive income of associates 132 28 72 34 -8 23
Total other comprehensive income for the period 9,550 3,668 3,000 2,273 -1,377 1,067
Total comprehensive income for the period -65,212 231,633 62,884 110,299 50,189 82,158
Attributable to:
Owners of the Parent Company -65,175 231,708 62,891 110,319 50,161 82,149
Non-controlling interest -37 -74 -7 -20 28 9
Total comprehensive income for the period -65,212 231,633 62,884 110,299 50,189 82,158
Consolidated Balance Sheet, in summary
SEK m 12/31 2022 12/31 2021
ASSETS
Goodwill 63,334 55,437
Other intangible assets 34,355 33,168
Property, plant and equipment 16,239 14,044
Shares and participations 550,556 638,336
Other financial investments 9,705 14,778
Long-term receivables included in net debt 945 1,964
Other long-term receivables 2,873 2,727
Total non-current assets 678,006 760,454
Inventories 9,583 6,767
Shares and participations in trading operation 873 375
Other current receivables 9,598 9,412
Cash, bank and short-term investments 26,304 18,534
Total current assets 46,358 35,088
TOTAL ASSETS 724,365 795,542
EQUITY AND LIABILITIES
Equity 605,653 683,505
Long-term interest bearing liabilities 89,436 83,966
Provisions for pensions and similar obligations 799 1,068
Other long-term provisions and liabilities 14,973 13,026
Total non-current liabilities 105,209 98,059
Current interest bearing liabilities 1,783 3,255
Other short-term provisions and liabilities 11,719 10,722
Total current liabilities 13,502 13,977
TOTAL EQUITY AND LIABILITIES 724,365 795,542

Consolidated Statement of Changes in Equity, in summary

SEK m 2022 2021
Opening balance 1/1 683,505 462,775
Profit for the period -74,762 227,965
Other comprehensive income for the period 9,550 3,668
Total comprehensive income for the period -65,212 231,633
Dividend to shareholders -12,254 -10,722
Changes in non-controlling interest -282 -991)
Effect of long-term share-based remuneration 42 64
Purchase of own shares -147 -147
Closing balance 605,653 683,505
1) Includes reclassification of non-controlling interest amounting to SEK -620m.
Attributable to:
Owners of the Parent Company 604,865 682,614
Non-controlling interest 788 891
Total equity 605,653 683,505
Consolidated Cash Flow, in summary
SEK m 2022 2021
Operating activities
Dividends received 11,507 11,254
Cash receipts 50,099 39,488
Cash payments -41,315 -32,904
Cash flows from operating activities before net interest and income tax 20,291 17,838
Interest received/paid -2,570 -2,143
Income tax paid -1,111 -1,440
Cash flows from operating activities 16,610 14,256
Investing activities
Acquisitions1) -4,434 -9,695
Divestments2) 11,696 16,779
Increase in long-term receivables -184 -93
Decrease in long-term receivables 38 101
Divestments of associated companies - 2,126
Acquisitions of subsidiaries, net effect on cash flow -2,318 -8,915
Divestments of subsidiaries, net effect on cash flow 83 4,079
Increase in other financial investments3) -9,534 -25,603
Decrease in other financial investments4) 14,292 14,103
Net change, short-term investments5) -13,102 8,079
Acquisitions of property, plant and equipment -4,368 -3,799
Proceeds from sale of property, plant and equipment 373 68
Net cash used in investing activities -7,458 -2,772
Financing activities
New share issue 21 494
Borrowings 13,273 6,172
Repayment of borrowings -15,965 -8,968
Repurchases of own shares -147 -149
Dividend paid -12,286 -10,722
Net cash used in financing activities -15,104 -13,174
Cash flows for the period -5,952 -1,690
Cash and cash equivalents at the beginning of the year 18,330 19,670
Exchange difference in cash 787 350
Cash and cash equivalents at the end of the period 13,164 18,330

1) Acquisitions include investments in listed and unlisted companies not defined as subsidiaries.

2) Divestments include sale of listed and unlisted companies not defined as subsidiaries.

3) Increase in other financial investments include acquisition of bond with maturity later than 1 year.

4) Decrease in other financial investments include disposals of reclassification of bonds with maturity later than 1 year.

5) Net changes, short-term investments includes acquisitions and disposals of bonds and certificates with maturity within 1 year.

Performance by Business Area Q4 2022

SEK m Listed
Companies
Patricia
Industries
Investments in
EQT
Investor
Groupwide
Total
Dividends 1,416 - 244 0 1,661
Changes in value 50,895 -326 461 16 51,046
Net sales - 14,168 - - 14,168
Cost of goods and services sold - -7,876 - - -7,876
Sales and marketing cost - -2,130 - - -2,130
Administrative, research and development and other operating cost - -2,581 -2 -8 -2,591
Management cost -45 -96 -3 -44 -188
Share of results of associates - -1,200 - - -1,200
Operating profit/loss 52,267 -41 700 -36 52,889
Net financial items - -20 - -752 -773
Income tax - -609 - 59 -550
Profit/loss for the period 52,267 -670 700 -729 51,567
Non-controlling interest - -37 - 0 -38
Net profit/loss for the period attributable to the Parent Company 52,267 -708 700 -729 51,529
Other effects on equity - -1,923 516 60 -1,347
Contribution to net asset value 52,267 -2,631 1,216 -670 50,182
Net asset value by business area 12/31 2022
Carrying amount 475,296 70,110 70,050 -328 615,128
Investors net debt/-cash - 11,823 - -22,086 -10,263
Total net asset value including net debt/-cash 475,296 81,933 70,050 -22,413 604,865

Performance by Business Area Q4 2021

SEK m Listed
Companies
Patricia
Industries
Investments in
EQT
Investor
Groupwide
Total
Dividends 3,134 - 209 3 3,346
Changes in value 50,220 366 27,329 -12 77,903
Net sales - 11,037 - - 11,037
Cost of goods and services sold - -5,997 - 0 -5,997
Sales and marketing cost - -1,631 - - -1,631
Administrative, research and development and other operating cost 0 -2,118 -1 -4 -2,124
Management cost -34 -69 -3 -52 -158
Share of results of associates - -20 - - -20
Operating profit/loss 53,320 1,568 27,534 -66 82,356
Net financial items - -881 - -260 -1,141
Income tax - -152 - 28 -124
Profit/loss for the period 53,320 535 27,534 -297 81,091
Non-controlling interest - 7 - 0 7
Net profit/loss for the period attributable to the Parent Company 53,320 542 27,534 -297 81,098
Other effects on equity - 882 62 9 953
Contribution to net asset value 53,320 1,424 27,596 -289 82,051
Net asset value by business area 12/31 2021
Carrying amount 515,078 65,758 116,640 -371 697,105
Investors net debt/-cash - 12,505 - -26,997 -14,491
Total net asset value including net debt/-cash 515,078 78,263 116,640 -27,367 682,614

Performance by Business Area 2022

Listed Patricia Investments in Investor
SEK m Companies Industries EQT Groupwide Total
Dividends 10,935 1 488 3 11,427
Changes in value -38,638 -825 -43,306 -14 -82,783
Net sales - 51,812 - - 51,812
Cost of goods and services sold - -28,546 - - -28,546
Sales and marketing cost - -7,708 - - -7,708
Administrative, research and development and other operating cost - -9,789 -6 -30 -9,824
Management cost -148 -336 -11 -130 -624
Share of results of associates - -1,176 - - -1,176
Operating profit/loss -27,851 3,433 -42,834 -171 -67,423
Net financial items - -2,321 - -3,940 -6,261
Income tax - -1,080 - 1 -1,079
Profit/loss for the period -27,851 32 -42,834 -4,109 -74,762
Non-controlling interest - 81 - 0 81
Net profit/loss for the period attributable to the Parent Company -27,851 113 -42,834 -4,110 -74,681
Dividend to shareholders - - - -12,254 -12,254
Other effects on equity - 6,531 2,464 191 9,186
Contribution to net asset value -27,851 6,645 -40,370 -16,173 -77,749
Net asset value by business area 12/31 2022
Carrying amount 475,296 70,110 70,050 -328 615,128
Investors net debt/-cash - 11,823 - -22,086 -10,263
Total net asset value including net debt/-cash 475,296 81,933 70,050 -22,413 604,865

Performance by Business Area 2021

Listed Patricia Investments in Investor
SEK m Companies Industries EQT Groupwide Total
Dividends 10,834 - 418 2 11,254
Changes in value 148,616 1,722 63,174 -6 213,505
Net sales - 40,737 - - 40,737
Cost of goods and services sold - -21,743 - 0 -21,743
Sales and marketing cost - -6,072 - - -6,072
Administrative, research and development and other operating cost 0 -8,391 -5 -24 -8,420
Management cost -123 -261 -9 -136 -530
Share of results of associates - 2,938 - - 2,938
Operating profit/loss 159,327 8,928 63,578 -164 231,669
Net financial items - -1,791 - -1,556 -3,347
Income tax - -312 - -45 -357
Profit/loss for the period 159,327 6,825 63,578 -1,765 227,965
Non-controlling interest - 100 - 0 100
Net profit/loss for the period attributable to the Parent Company 159,327 6,926 63,578 -1,765 228,065
Dividend to shareholders - - - -10,722 -10,722
Other effects on equity - 2,968 410 56 3,435
Contribution to net asset value 159,327 9,894 63,988 -12,431 220,778
Net asset value by business area 12/31 2021
Carrying amount 515,078 65,758 116,640 -371 697,105
Investors net debt/-cash - 12,505 - -26,997 -14,491
Total net asset value including net debt/-cash 515,078 78,263 116,640 -27,367 682,614
Parent Company Income Statement, in summary
SEK m 2022 2021 H2 2022 H2 2021
Dividends 10,224 10,286 2,357 3,904
Changes in value -35,006 128,188 49,639 55,886
Net sales 15 10 7 6
Operating cost -468 -420 -247 -222
Operating profit/loss -25,236 138,063 51,756 59,573
Profit/loss from financial items
Net financial items -3,159 -1,273 -1,936 -636
Profit/loss after financial items -28,395 136,791 49,820 58,937
Income tax - - - -
Profit/loss for the period -28,395 136,791 49,820 58,937
Parent Company Balance Sheet, in summary
SEK m 12/31 2022 12/31 2021
ASSETS
Intangible assets and Property, plant and equipment 18 18
Financial assets 487,756 529,377
Total non-current assets 487,774 529,395
Current receivables 489 379
Cash and cash equivalents - -
Total current assets 489 379
TOTAL ASSETS 488,263 529,773
EQUITY AND LIABILITIES
Equity 431,034 471,763
Provisions 128 137
Non-current liabilities, interest bearing 45,940 44,625
Total non-current liabilities 46,068 44,762
Current liabilities, interest bearing 0 946
Current liabilities 11,160 12,303
Total current liabilities 11,160 13,249
TOTAL EQUITY AND LIABILITIES 488,263 529,773

Financial instruments

The numbers below are based on the same accounting and valuation policies as used in the preparation of the company's most recent annual report. For information regarding financial instruments in level 2 and level 3, see Note 31, Financial Instruments, in Investor's Annual Report 2021.

Valuation techniques, level 3

Fair value, SEK m Range
Group 12/31 2022 12/31 2021 Valuation technique Input 12/31 2022 12/31 2021
Shares and participations 34,184 33,756 Last round of financing n/a n/a n/a
Comparable companies EBITDA multiples n/a n/a
Comparable companies Sales multiples 0.9 – 3.3 3.1 – 4.4
Comparable transactions Sales multiples 1.2 – 2.5 2.2 – 3.6
NAV n/a n/a n/a
Other financial investments 25 160 Discounted cash flow Market interest rate n/a n/a
Long-term and current receivables 2,543 3,745 Discounted cash flow Market interest rate n/a n/a
Long-term interest bearing liabilities 17 46 Discounted cash flow Market interest rate n/a n/a
Other provisions and liabilities 6,735 6,036 Discounted cash flow n/a n/a n/a

All valuations in level 3 are based on assumptions and judgments that management considers to be reasonable based on the circumstances prevailing at the time. Changes in assumptions may result in adjustments to reported values and the actual outcome may differ from the estimates and judgments that were made. Shares and participations in level 3 are mainly fund investments within EQT. Unlisted holdings in funds are measured at Investor's share of the value that the fund manager reports for all unlisted fund holdings (Net Asset Value) and is normally updated when a new valuation is received. The value change on Investor's investments in EQT funds are reported with a one-quarter lag. Part of the unlisted portfolio is valued based on comparable companies, and the value is dependent on the level of the multiples. The multiple ranges provided in the note show the minimum and maximum value of the actual multiples applied in these valuations. A 10 percent change of the multiples would have an effect on this part of the unlisted portfolio of approximately SEK 200m (120). For the derivatives, a parallel shift of the interest rate curve by one percentage point would affect the value by approximately SEK 660m (900).

Financial assets and liabilities by level

The table below indicates how fair value is measured for the financial instruments recognized at fair value in the Balance Sheet. The financial instruments are presented in three categories, depending on how the fair value is measured: Level 1: According to quoted prices in active markets for identical instruments

Level 2: According to directly or indirectly observable inputs that are not included in level 1

Level 3: According to inputs that are unobservable in the market

Financial instruments - fair value

12/31 2022 12/31 2021
Group Total
carrying
Total
carrying
SEK m Level 1 Level 2 Level 3 Other1) amount Level 1 Level 2 Level 3 Other1) amount
Financial assets
Shares and participations 511,703 2,167 34,184 2,502 550,556 598,769 2,355 33,756 3,456 638,336
Other financial investments 9,591 - 25 89 9,705 14,543 - 160 75 14,778
Long-term receivables included in
net debt
- - 945 - 945 - - 1,964 - 1,964
Other long-term receivables - - 1,598 1,275 2,873 - - 1,781 946 2,727
Shares and participations in
trading operation
873 - - - 873 375 - - - 375
Other current receivables 0 41 - 9,557 9,598 22 1 - 9,389 9,412
Cash, bank and short-term
investments
18,767 - - 7,537 26,304 9,356 - - 9,178 18,534
Total 540,935 2,208 36,752 20,960 600,855 623,065 2,357 37,661 23,043 686,125
Financial liabilities
Long-term interest bearing
liabilities
- - 17 89,420 89,4362) - - 46 83,920 83,9662)
Other long-term provisions and
liabilities
- - 6,692 8,282 14,973 - - 5,935 7,091 13,026
Short-term interest bearing
liabilities
- 48 - 1,735 1,7833) - 228 - 3,027 3,2553)
Other short-term provisions and
liabilities
179 77 44 11,419 11,719 117 131 101 10,373 10,722
Total 179 125 6,752 110,856 117,912 117 359 6,082 104,411 110,969

1) To enable reconciliation with balance sheet items, financial instruments not valued at fair value as well as other assets and liabilities that are included within balance sheet items

have been included within Other. 2) The Group's loans are valued at amortized cost. Fair value on long-term loans amounts to SEK 80,997m (88,354).

3) The Group's loans are valued at amortized cost. Fair value on short-term loans amounts to SEK 1,783m (3,262).

Changes in financial assets and liabilities in Level 3

Group 12/31 2022

Other Long-term
receivables
Long-term
interest
Other long
term
Other
SEK m Shares and
participations
financial
investments
included in
net debt
bearing
liabilities
provisions and
liabilities
current
liabilities
Opening balance at the beginning of the year 33,756 160 3,745 46 5,935 101
Total gain or losses in profit or loss statement
in line Changes in value 3,789 -26 -139 - -1 -
in line Net financial items - -4 -1,168 -29 209 -55
in line Cost of goods and services sold 0 - - - -4 -
Reported in other comprehensive income
in line Cash flow hedges - - 144
in line Foreign currency translation adjustment 3,308 18 44 - 562 1
Acquisitions 3,671 - - - - -
Divestments -10,341 -116 - - - -
Issues - - 11 - - -
Settlements - - -95 - -9 -3
Transfer out of Level 3 - -6 - - - -
Carrying amount at end of the period 34,184 25 2,543 17 6,692 44
Total unrealized gains/losses for the period included in profit/loss for financial
instruments held at the end of the period
Changes in value -2,435 - - - -65 -
Net financial items - - -1,168 29 - -
Total -2,435 - -1,168 29 -65 -

Changes in financial assets and liabilities in Level 3

Group 12/31 2021

Other Long-term
receivables
Long-term
interest
Other long
term
Other
SEK m Shares and
participations
financial
investments
included in
net debt
bearing
liabilities
provisions and
liabilities
current
liabilities
Opening balance at the beginning of the year 24,409 120 3,586 59 4,179 117
Total gain or losses in profit or loss statement
in line Changes in value 13,271 23 228 - -113 -
in line Net financial items - -11 -50 -14 680 8
Reported in other comprehensive income
in line Foreign currency translation adjustment 813 13 10 - 226 0
Acquisitions 7,386 51 - - 1,398 -
Divestments -12,078 -34 -50 - - -
Issues - - 43 - 6 3
Settlements - - -20 - -442 -28
Transfer out of Level 3 -45 - - - - -
Carrying amount at end of the period 33,756 160 3,745 46 5,935 101
Total unrealized gains/losses for the period included in profit/loss for financial
instruments held at the end of the period
Changes in value -8,414 - - - 1,613 -
Net financial items - - -50 14 -481 -
Total -8,414 - -50 14 1,132 -

Revenue from contracts with customers

Group 2022 Field of operation
SEK m Healthcare
equipment
Healthcare
services
Real estate Osmolality
testing
Gripping and
moving
solutions
Total
Geographical market
Sweden 853 236 285 1 115 1,490
Scandinavia, excl. Sweden 1,385 17 - 5 47 1,454
Europe, excl. Scandinavia 11,022 144 - 221 944 12,331
U.S. 29,343 365 - 908 671 31,287
North America, excl. U.S. 944 2 - 63 123 1,132
South America 383 0 - 12 88 482
Africa 317 2 - 4 9 333
Australia 1,051 2 - 15 16 1,083
Asia 1,648 4 - 130 438 2,219
Total 46,946 772 285 1,359 2,450 51,812
Category
Sales of products 45,020 18 - 1,126 2,421 48,585
Sales of services 1,852 754 - 233 30 2,868
Revenues from leasing 65 - 282 - - 347
Other income 10 - 3 - - 12
Total 46,946 772 285 1,359 2,450 51,812
Sales channels
Through distributors 26,732 12 - 588 937 28,268
Directly to customers 20,214 760 285 771 1,514 23,544
Total 46,946 772 285 1,359 2,450 51,812
Timing of revenue recognition
Goods and services transferred
at a point of time 46,489 530 - 1,288 2,450 50,758
Goods and services transferred
over time 457 242 285 70 - 1,054
Total 46,946 772 285 1,359 2,450 51,812

Revenue from contracts with customers

Group 2021 Field of operation

Gripping and
Healthcare Healthcare Osmolality moving
SEK m equipment services Hotel Real estate testing solutions Total
Geographical market
Sweden 747 359 68 229 1 102 1,506
Scandinavia, excl. Sweden 1,182 8 - - 4 51 1,246
Europe, excl. Scandinavia 10,006 53 - - 203 721 10,982
U.S. 21,463 261 - - 534 436 22,694
North America, excl. U.S. 750 0 - - 41 94 885
South America 281 - - - 9 58 347
Africa 483 0 - - 4 6 492
Australia 908 - - - 12 11 930
Asia 1,295 26 - - 73 260 1,654
Total 37,116 707 68 229 880 1,738 40,737
Category
Sales of products 35,594 - - - 779 1,713 38,087
Sales of services 1,443 707 68 - 101 25 2,343
Revenues from leasing 70 - - 224 - - 293
Other income 9 - - 5 - - 14
Total 37,116 707 68 229 880 1,738 40,737
Sales channels
Through distributors 20,813 - 41 - 432 691 21,977
Directly to customers 16,303 707 27 229 447 1,047 18,760
Total 37,116 707 68 229 880 1,738 40,737
Timing of revenue recognition
Goods and services transferred
at a point of time 36,734 707 - - 856 1,738 40,035
Goods and services transferred
over time 382 - 68 229 23 - 702
Total 37,116 707 68 229 880 1,738 40,737

Reconciliations of significant Alternative Performance Measures

In the financial statements issued by Investor, Alternative Performance Measures (APMs) are disclosed, which complete measures that are defined or specified in the applicable financial reporting framework, such as revenue, profit or loss or earnings per share.

APMs are disclosed when they complement performance measures defined by IFRS. The basis for disclosed APMs are that they are used by management to evaluate the financial performance and in so believed to give analysts and other stakeholders valuable information.

Investor AB discloses the definitions of all APMs used on http://www.investorab.com/investors-media/investor-infigures/definitions and on pages 127-128 in the Annual Report 2021. Below reconciliations of significant APMs to the most directly reconcilable line item, subtotal or total presented in the financial statements of the corresponding period are disclosed.

Gross cash

Gross cash or Investor's cash and readily available placements are defined as the sum of cash and cash equivalents, short-term investments and interest-bearing current and long-term receivables. Deductions are made for items related to subsidiaries within Patricia Industries.

Group 12/31 2022,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross cash
Group 12/31 2021,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross cash
Other financial Other financial
investments 9,705 -116 9,590 investments 14,778 -236 14,542
Cash, bank and short Cash, bank and short
term investments 26,304 -7,361 18,943 term investments 18,534 -9,121 9,413
Gross cash 36,009 -7,476 28,533 Gross cash 33,311 -9,357 23,955

Gross debt

Gross debt is defined as interest-bearing current and long-term liabilities, including pension liabilities, less derivatives with positive value related to the loans. Deductions are made for items related to subsidiaries within Patricia Industries.

Group 12/31 2022,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross debt
Group 12/31 2021,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross debt
Receivables included
in net debt
945 -148 797 Receivables included
in net debt
1,964 - 1,964
Loans -91,220 51,728 -39,492 Loans -87,221 46,919 -40,301
Provision for pensions -799 699 -101 Provision for pensions -1,068 959 -109
Gross debt -91,074 52,278 -38,796 Gross debt -86,324 47,878 -38,446

Net debt

Gross debt less gross cash at Balance Sheet date.

Group 12/31 2022,
SEK m
Group 12/31 2021,
SEK m
Investor's gross cash -28,533 Investor's gross cash -23,955
Investor's gross debt 38,796 Investor's gross debt 38,446
Investor's net debt 10,263 Investor's net debt 14,491

Total assets

The net of all assets and liabilities not included in net debt. Total reported assets are based on reported values according to IFRS. Total adjusted assets are adjusted for estimated market values for Patricia Industries' major subsidiaries and partner-owned investments.

Group 12/31 2022,
SEK m
Consolidated
balance sheet
Deductions
related to non
controlling
interest
Investor's
net asset
value
Group 12/31 2021,
SEK m
Consolidated
balance sheet
Deductions
related to non
controlling
interest
Investor's
net asset
value
Equity
Investor's net debt
605,653 -788 604,865
10,263
Equity
Investor's net debt
683,505 -891 682,614
14,491
Total reported
assets
615,128 Total reported
assets
697,105
Adjustment for
estimated market
value Patricia
Industries holdings
68,385 Adjustment for
estimated market
value Patricia
Industries holdings
78,348
Total adjusted
assets
683,513 Total adjusted
assets
775,453

Net debt ratio (leverage)

Net debt ratio or leverage is defined as Net debt/Net cash as a percentage of total adjusted assets. The target leverange range is 0-10 percent (net debt to total adjusted assets) over a business cycle.

Group 12/31 2022, SEK m Net debt ratio Group 12/31 2021, SEK m Net debt ratio
Investor's net debt 10,263 = 1.5% Investor's net debt 14,491 = 1.9%
Total adjusted assets 683,513 Total adjusted assets 775,453

Reported net asset value

Reported net asset value is equal to Investor's net asset value and equity attributable to owners of the Parent Company.

Adjusted net asset value

Net asset value based on estimated market values for Patricia Industries' major subsidiaries and partner-owned investments. The estimated market values are mainly based on valuation multiples, typically Enterprise value (EV)/Last 12 months' operating profit, for relevant listed peers and indices. More information about the assessment basis can be found in section Patricia Industries - valuation overview on page 8 and Patricia Industries, overview of estimated market values on page 32. In the table below there are a reconciliation between Reported net asset value and Adjusted net asset value. More details regarding the differences can be found in the table Net asset value overview on page 4.

Group 12/31 2022,
SEK m
Group 12/31 2021,
SEK m
Reported net asset value 604,865 Reported net asset value 682,614
Reported value for net assets Patricia
Industries
-70,110 Reported value for net assets Patricia
Industries
-65,758
Estimated market value Patricia
Industries holdings
138,495 Estimated market value Patricia
Industries holdings
144,106
Adjusted net asset value 673,250 Adjusted net asset value 760,962

Reported net asset value, SEK per share

Equity attributable to shareholders of the Parent Company in relation to the number of shares outstanding at the Balance Sheet date.

Group 12/31 2022, SEK m Net asset value,
SEK per share
Group 12/31 2021, SEK m Net asset value,
SEK per share
Investor's reported net asset value 604,865 Investor's reported net asset value 682,614
Number of shares, excluding own
shares
=
3,063,045,776
197 Number of shares, excluding own
shares
=
3,063,457,767
223

Adjusted net asset value, SEK per share

Total assets, including estimated market values for Patricia Industries' major subsidiaries and partner-owned investments, less net debt in relation to the number of shares outstanding at the Balance Sheet date.

Group 12/31 2022, SEK m Net asset value,
SEK per share
Group 12/31 2021, SEK m Net asset value,
SEK per share
Investor's adjusted net asset value 673,250 Investor's adjusted net asset value 760,962
Number of shares, excluding own
shares
=
3,063,045,776
220 Number of shares, excluding own
shares
=
3,063,457,767
248

Patricia Industries, key figures overview1)

FY Q4 Q3 Q2 Q1 FY Q4 Q3 Q2 Q1 FY Q4
2022 2022 2022 2022 2022 2021 2021 2021 2021 2021 2020 2020
Mölnlycke (EUR m)
Sales
1,828 474 469 459 426 1,686 420 405 417 443 1,793 554
Sales growth, % 8 13 16 10 -4 -6 -24 -15 16 11 16 38
Organic growth, 4 9 9 5 -7 -6 -26 -16 18 14 18 41
constant currency, %
EBITDA
476 105 134 125 112 485 106 112 123 146 536 174
EBITDA, % 26.1 22.2 28.6 27.2 26.4 28.8 25.1 27.5 29.4 32.9 29.9 31.4
EBITA2) 410 89 118 108 96 421 89 95 107 130 475 159
EBITA, % 22.4 18.7 25.1 23.6 22.6 25.0 21.2 23.4 25.6 29.4 26.5 28.8
Operating cash flow 298 78 119 73 28 382 128 91 84 79 470 229
Net debt 1,621 1,621 1,418 1,478 1,522 1,510 1,510 1,568 1,623 1,473 1,492 1,492
Employees
Laborie (USD m)
8,775 8,775 8,800 8,625 8,340 8,315 8,315 8,175 8,040 7,850 7,910 7,910
Sales 339 89 85 87 79 313 84 74 80 76 230 69
Sales growth, % 8 6 15 9 4 36 20 19 85 37 12 23
Organic growth, 12 9 20 9 4 21 14 6 67 11 -19 -14
constant currency, %
EBITDA
97 29 26 23 18 93 22 20 28 23 44 22
EBITDA, % 28.6 32.7 31.3 26.8 23.1 29.9 26.4 27.7 34.5 30.9 19.1 31.2
EBITA2) 90 27 25 22 17 83 20 18 25 20 37 19
EBITA, % 26.7 30.6 29.5 25.0 21.0 26.6 24.2 24.4 31.3 26.7 16.0 27.5
Operating cash flow 49 14 20 13 2 60 20 16 22 2 21 15
Net debt
Employees
454
895
454
895
461
910
475
885
455
805
424
780
424
780
366
780
396
775
400
825
403
870
403
870
Sarnova (USD m)
Sales 917 245 239 211 222 835 233 230 183 191 725 199
Sales growth, % 10 6 4 15 16 15 17 34 10 1 12 29
Organic growth,
constant currency, %
2 6 -5 6 3 0 0 14 -3 -10 9 19
EBITDA 135 41 36 28 30 104 30 24 23 27 78 20
EBITDA, % 14.8 16.8 14.9 13.4 13.7 12.5 13.1 10.3 12.6 14.2 10.8 9.9
EBITA2) 118 37 31 24 26 91 25 21 20 24 69 17
EBITA, % 12.9 15.0 13.1 11.5 11.8 10.9 10.9 9.1 11.0 12.7 9.5 8.5
Operating cash flow 102 29 15 20 38 77 21 9 24 23 49 -6
Net debt
Employees
526
1,435
526
1,435
541
1,355
538
1,360
538
1,375
569
1,370
569
1,370
578
1,370
496
1,240
509
1,215
525
1,195
525
1,195
Permobil (SEK m)
Sales 5,248 1,545 1,410 1,177 1,116 4,062 1,119 1,054 981 908 3,944 1,021
Sales growth, % 29 38 34 20 23 3 10 12 8 -15 -11 -16
Organic growth,
constant currency, %
9 17 12 0 6 6 6 11 18 -7 -9 -10
EBITDA 1,071 389 317 187 177 782 192 211 187 192 826 225
EBITDA, % 20.4 25.1 22.5 15.9 15.9 19.2 17.2 20.1 19.0 21.1 20.9 22.0
EBITA2) 880 335 266 145 133 612 149 168 147 148 641 178
EBITA, % 16.8 21.7 18.9 12.3 12.0 15.1 13.3 16.0 15.0 16.3 16.3 17.4
Operating cash flow
Net debt
435
3,330
252
3,330
182
3,752
13
3,568
-13
3,388
214
3,166
37
3,166
90
3,026
-12
2,959
98
2,671
835
2,559
197
2,559
Employees 1,805 1,805 1,780 1,755 1,755 1,660 1,660 1,645 1,630 1,540 1,570 1,570
Advanced Instruments (USD m)
Sales 134 35 35 33 31 103 31 26 24 22 77 22
Sales growth, % 31 13 33 41 44 34 45 33 49 11 9 16
Organic growth,
constant currency, %
7 -5 3 16 20 24 18 26 47 11 9 16
EBITDA 45 11 12 8 14 38 12 3 12 11 37 10
EBITDA, % 33.6 32.1 35.9 22.7 44.3 37.1 37.1 13.3 50.9 50.4 47.7 48.5
EBITA2) 43 11 12 7 13 37 11 3 12 11 35 10
EBITA, %
Operating cash flow
32.1
35
30.6
7
34.3
16
21.3
8
42.8
5
35.7
32
35.8
10
11.9
7
49.5
9
48.9
6
46.0
34
47.2
12
Net debt 206 206 206 208 192 195 195 203 142 149 152 152
Employees 370 370 370 350 225 225 225 225 145 130 130 130
Piab (SEK m)
Sales 2,450 661 620 619 551 1,738 472 438 422 406 1,526 435
Sales growth, %
Organic growth,
41 40 42 47 36 14 8 25 23 2 20 36
constant currency, % 11 7 6 17 17 18 8 26 33 9 -4 12
EBITDA 619 122 163 173 161 485 109 130 126 121 420 124
EBITDA, % 25.2 18.4 26.2 27.9 29.3 27.9 23.1 29.6 29.8 29.8 27.5 28.5
EBITA2)
EBITA, %
530
21.6
97
14.7
139
22.4
152
24.5
142
25.9
409
23.5
81
17.2
113
25.9
110
26.0
105
25.9
359
23.5
107
24.6
Operating cash flow 411 113 138 102 58 376 79 106 104 87 364 85
Net debt 2,431 2,431 2,591 2,423 1,986 1,767 1,767 1,505 1,548 1,592 1,574 1,574
Employees 1,030 1,030 1,020 995 875 695 695 680 660 650 625 625
FY Q4 Q3 Q2 Q1 FY Q4 Q3 Q2 Q1 FY Q4
2022 2022 2022 2022 2022 2021 2021 2021 2021 2021 2020 2020
BraunAbility (USD m)
Sales 929 242 252 211 224 692 184 192 171 146 567 150
Sales growth, % 34 32 31 24 53 22 22 26 86 -15 -23 -21
Organic growth,
constant currency, %
28 25 28 19 43 17 14 17 81 -16 -24 -22
EBITDA 86 24 23 17 22 52 13 17 12 10 44 12
EBITDA, % 9.3 9.9 9.3 8.1 9.8 7.5 7.2 9.0 7.1 6.6 7.7 7.9
EBITA2) 67 19 19 13 17 35 9 13 8 6 29 8
EBITA, % 7.2 7.7 7.5 5.9 7.7 5.1 4.6 6.6 4.9 4.1 5.1 5.2
Operating cash flow 46 14 19 3 9 38 8 23 6 2 20 30
Net debt 284 284 288 302 302 300 300 307 326 190 189 189
Employees 1,945 1,945 1,995 1,890 1,850 1,825 1,825 1,825 1,760 1,495 1,555 1,555
Vectura (SEK m)
Sales 302 78 74 75 74 279 71 61 66 81 298 90
Sales growth, % 8 9 23 14 -8 -6 -20 -21 -3 29 9 24
EBITDA 178 42 45 47 44 172 42 40 41 48 184 60
EBITDA, % 58.9 53.9 60.4 62.0 59.6 61.5 59.2 66.2 62.1 59.6 61.9 67.4
EBITA adjusted2) 50 10 13 15 13 45 7 13 13 12 34 2
EBITA, % 16.7 12.5 17.0 20.1 17.3 16.0 9.5 21.7 19.8 14.4 11.4 2.1
Operating cash flow -614 -160 -76 -252 -126 -355 -97 -52 -160 -46 -1,450 -574
Net debt 5,223 5,223 4,984 4,376 4,343 3,963 3,963 3,453 2,537 4,361 4,302 4,302
Real estate,
market value
9,650 9,650 8,388 9,182
Employees 49 49 44 41 38 33 33 31 31 34 31 31
Atlas Antibodies (SEK m)
Sales 398 98 100 104 95 324 81 86 81 76 247 66
Sales growth, % 23 21 16 29 26 31 23 38 43 23 13 24
Organic growth, 14 9 7 21 20 34 19 39 47 32 15 30
constant currency, %
EBITDA
187 42 52 48 45 162 42 45 36 40 124 33
EBITDA, % 47.0 42.8 52.3 45.7 47.4 50.1 51.4 52.3 43.9 52.7 50.2 50.5
EBITA2) 165 36 46 42 40 143 37 40 31 36 107 29
EBITA, % 41.4 37.0 46.4 40.4 41.9 44.2 45.0 46.5 38.1 47.0 43.3 44.1
Operating cash flow 94 17 45 18 14 115 24 56 13 23 78 33
Net debt 342 342 352 391 403 406 406 429 22 24 -117 -117
Employees 130 130 120 120 120 115 115 110 115 110 95 95
Three Scandinavia
Sales, SEK m 11,834 3,283 3,025 2,798 2,728 10,750 2,925 2,696 2,543 2,586 10,668 2,873
Sweden, SEK m 7,668 2,160 1,942 1,817 1,749 6,946 1,929 1,740 1,617 1,659 6,818 1,879
Denmark, DKK m 2,904 756 755 700 694 2,787 730 697 676 683 2,740 723
EBITDA, SEK m 3,729 973 948 917 891 3,535 931 892 849 863 3,934 923
Sweden, SEK m 2,732 706 695 675 656 2,564 636 662 625 641 2,725 616
Denmark, DKK m 694 180 176 172 167 711 216 168 164 164 861 224
EBITDA, % 31.5 29.7 31.3 32.8 32.7 32.9 31.8 33.1 33.4 33.4 36.9 32.1
Sweden 35.6 32.7 35.8 37.2 37.5 36.9 33.0 38.1 38.6 38.6 40.0 32.8
Denmark 23.9 23.8 23.3 24.6 24.0 25.5 29.6 24.1 24.2 24.0 31.4 30.9
Net debt, SEK m 7,294 7,294 6,969 6,731 6,406 6,498 6,498 5,940 6,070 6,173 6,341 6,341
Employees 1,790 1,790 1,765 1,715 1,735 1,735 1,735 1,685 1,775 1,740 1,775 1,775

1) For information regarding Alternative Performance Measures in the table, see page 18. Definitions can be found on Investor's website.

2) EBITA is defined as operating profit before acquisition-related amortizations.

Valuation methodology
Listed Companies Share price (bid) for the class of shares held by Investor, with the exception of Saab, Electrolux and
Electrolux Professional for which the most actively traded share class is used.
Ownership calculated in accordance with the disclosure of regulations of Sweden's Financial Instruments
Trading Act (LHF). ABB, Accelleron, AstraZeneca, Nasdaq and Wärtsilä in accordance with Swiss, British,
U.S. and Finnish regulations.
Includes market value of derivatives related to investments if applicable.
Patricia Industries
Subsidiaries Reported value based on the acquisition method. As supplementary information, subsidiaries are also
presented at estimated market values, mainly based on valuation multiples for relevant listed peers and
indices. Other methodologies may also be used, for example relating to real estate assets. New investments
valued at invested amount during the first 18 months following the acquisition.
Partner-owned investments Reported value based on the equity method. As supplementary information, partner-owned investments are
also presented at estimated market values, mainly based on valuation multiples for relevant listed peers and
indices.
Financial Investments Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid).
Investments in EQT Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid).

Patricia Industries, overview of estimated market values

Supplementary information In addition to reported values, which are in accordance with IFRS, Investor provides estimated market values
for the wholly-owned subsidiaries and partner-owned investments within Patricia Industries in order to
facilitate the evaluation of Investor's net asset value. This supplementary, non-GAAP information also
increases the consistency between the valuation of Listed Companies and our major wholly-owned
subsidiaries and partner-owned Three Scandinavia.
Estimated market values While the estimated market values might not necessarily reflect our view of the intrinsic values, they reflect
how the stock market values similar companies.
Methodology The estimated market values are mainly based on valuation multiples (median), typically Enterprise value
(EV)/Last 12 months' operating profit, for relevant listed peers and indices. We define EV as quarterly
volume-weighted average share price (VWAP) plus closing date net debt. While we focus on EBITA when
evaluating the performance of our companies, for valuation purposes, EBITDA multiples are more commonly
available, and therefore often used. From the estimated EV, net debt is deducted, and the remaining equity
value is multiplied with Patricia Industries' share of capital.
Adjustments Operating profit is adjusted to reflect, for example, pro forma effects of completed add-on acquisitions and
certain non-recurring items. An item is only viewed as non-recurring if it exceeds a certain amount set for
each company, is unlikely to affect the company again, and does not result in any future benefit or cost.
Acquisitions made less than 18 months ago are valued at cost.

Investor in brief

Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board representation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include, among others, ABB, Atlas Copco, Ericsson, Mölnlycke and SEB.

Our purpose

We create value for people and society by building strong and sustainable businesses.

Our ultimate target

Our ultimate target is to generate an attractive total return. Our long-term return requirement is the risk free interest rate plus an equity risk premium, in total 8-9 percent annually.

Our strategic priorities

Grow net asset value

We own high-quality companies and are an engaged owner, supporting our companies to achieve profitable growth. We strive to allocate our capital wisely.

Pay a steadily rising dividend

Our goal is to pay a steadily rising dividend. Our dividend policy is supported by cash flow from all three business areas: Listed Companies, Patricia Industries and Investments in EQT.

Deliver on our ESG targets

We firmly believe that sustainability integrated in the business model is a prerequisite for creating long-term value. Our three focus areas with specific targets are Business Ethics & Governance, Climate & Resource Efficiency and Diversity & Inclusion.

Our operating priorities

  • Engaged ownership
  • Ensure an attractive portfolio
  • Operate efficiently
  • Maintain financial flexibility

Talk to a Data Expert

Have a question? We'll get back to you promptly.